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ABSTRACT 
The ability of designing, biofabricating and programming engineered tissue constructs, as 
well as modularly assembling them to achieve the engineering of heterotypic living systems is a 
key element for the progress of “New Biology”. This perspective consists of utilizing 
engineering concepts for design of complex systems and combining with the principles and 
properties of multiple disciplines in cellular biology at various length scales to drive composition 
of living material that are organized in a way that allows for the emergence of novel 
functionalities. Advances in this field can constitute an experimental platform that can guide the 
discovery of factors that allow the emergence of properties that can translate into a richer toolbox 
with which to address real world problems.     
One important example is the development of biological machines, namely consisting of 
motor neurons as a source of processing and activation and skeletal muscle as the actuator of the 
system. Towards this goal, advances in the generation of a neuro-muscular driven machine 
require an expansion of design parameters and arrangement of the assembled parts, guided by 
parameters established by natural processes. This dissertation presents advances on the 
expansion of this toolbox for the engineering of multicellular living systems consisting of muscle 
calls and motor neurons. The dissertation focuses on the modulation of the electrical activity of 
motor neuronal networks, the biofabrication of neural tissue containing motor neurons, and the 
redesigning of previous muscle-based walking robots for higher force generation.   
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First of all, the ability to uncover in-vitro methods to “reprogram” neural networks 
responsible for guiding the actuation of muscle is critical to engineer the dynamic functionalities 
needed in these biological machines.  In this work, motor neurons were differentiated from 
mouse embryonic stem cells, which have been transfected to express a GFP reporter under the 
Hb9 promoter as well as Channelrhodopsin, to enable optogenetic stimulation of these neurons, 
which was used to design the training regimens. Past efforts have not considered reprogramming 
in terms of evoking long-term changes in firing patterns of in-vitro networks by training 
regimens during stages of neural development. Thus, in this dissertation, short and long-term 
programming of neural networks was explored by using optical stimulation to induce training 
regimens implemented during neurogenesis and synaptogenesis, and ultimately demonstrating 
correlation between these and the resulting plastic responses.  
Furthermore, to design multicellular engineered living systems subunits that could 
facilitate the assembly of heterotypic biological machines, a novel biofabrication approach is 
proposed to form functional in-vitro neural tissue mimics (NTM) using mouse embryonic stem 
cells, a fibrin matrix, and 3D printed molds. This method can provide a large degree of design 
flexibility for development of in-vitro functional neural tissue models of varying shapes and 
forms for applications in the developments of engineered living systems for therapeutic 
biomedical research, drug discovery and disease modeling, and new engineering and research 
models. This type of biological manufacturing method is a good representation of the utilization 
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and expansion of biological design principles to guide the creation of self-organized complex 
functional structures, thus enriching the toolbox for the top-down engineering approach. 
Finally, the development of skeletal muscle driven biological machines require optimized 
approaches for design given the mechanical dynamics between the actuating muscle and the 
scaffold. This means that advancing these biologically driven soft robots will involve employing 
different scaffold geometries and cellular constructs to enable a controllable emergence for 
increased production of force and functionality.  Having the flexibility of altering geometry 
while ensuring tissue viability can enable advancing functional output from these machines 
through the implementation of new construction concepts and fabrication approaches. 
Furthermore, a forward engineering approach was developed to design next generation biological 
machines via direct numerical simulations and subsequent fabrication of high force producing 
biological machines.  
The present thesis aims to propose the development of building blocks and modular 
technologies surrounding the realization of motor neuronal driven machines, through the 
implementation of effective training regimens to reprogram neural networks, implementing 
biofabrication techniques for neural tissues and optimizing design and scaling force produced by 
the muscle actuators in these biological machines. These stepwise enhancements in the 
engineering of the subunits are critical for the successful assembly of more complex structures 
and our understanding of how to build on these designs towards solving real world problems in 
medicine, environment, and manufacturing. 
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CHAPTER 1: INTRODUCTION AND OVERVIEW 
1.1 MOTIVATION 
The field of engineering complex living systems in-vitro has been expanding as a subfield 
within tissue engineering for the past few decades(1, 2). This field consists of the development of 
biohybrid designs which take advantage of fabrication techniques to construct platforms which 
guide the functionality of biological tissue in order to achieve a desired function. These designs 
are being expanded with the interest of recapitulating a larger diversity of biological behaviors, 
which can serve to address real world biomedical problems such as modeling diseases for drug 
testing and development as well as for studying therapeutic approaches in regenerative medicine. 
On the other hand, a growing interest has been the modeling of phenomena of interest to study 
the emergence of biological properties in a more controlled setting through effective research 
models (3). This mindset consists of understanding the complexity of biological development, 
which can be exceedingly difficult through conventional means of observing live organisms. 
This is due in part to limitations on experimental freedom imposed by the organisms as well as 
technological constraints that currently exists. However, it is the very complexity of the 
organisms which composes the primary obstacles towards studying these complex phenomena. 
Thus, through the effort of trying to recapitulate these biomimetic properties in a lab setting, the 
goal is to become aware of what factors can be decoupled, which are essential for the property to 
emerge and to what extent.  
 This has led to the birth of the unique perspective of visualizing biological tissue as a material 
source.  
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From this viewpoint, biological cells are a material that has multiple unique properties: it can 
grow, heal, respond to outside stimulus and learn. Along that mindset, analogous to how 
engineering with metal has evolved from understanding each metal’s physical property, (i.e. 
some metals being effective for electrical devices while others are more effective for building 
heavy physical structures), by understanding the biophysical, biochemical and biomechanical 
properties, the field will become more effective at engineering these in-vitro living systems. As 
the efforts have progressed, it has become clear the need to define design principles, or 
engineering principles which guide the use of biological knowledge towards recapitulating 
complex biological phenomena in-vitro. By a focused effort of creating a tissue engineering 
database, we can lay the grounds towards gaining a deeper understanding of how cooperative 
cell behavior leads to the formation of functional complex living systems. This would not only 
serve as an engineering-based approach of understanding the phenomena that happens in our 
bodies but would also serve to forward engineer these biohybrid systems to achieve more 
complex and, even perhaps, advanced functional outputs. This can have multiple positive 
repercussions in the way we study biological systems, as well as implement them for 
biomedicine.  
These types of constructs can lead to development of more advanced “organ-on-chips” to 
allow for optimized disease modeling and in turn more efficient drug discovery and screening 
(2).  On the other hand, realizing these systems with the expectation of addressing real-world 
problems through the engineering of biomimetic or bio-enhanced functionality gives the 
opportunity for development of unique and advantageous research models. This arises from the 
obstacles that currently limit the ability to engineer these multi-cellular living systems, as the 
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rules for the complexity that emerges during the interaction of biological structures at different 
levels of development still remains to be understood. Furthermore, one main engineering 
approach towards achieving these structures is a “top-down engineering” design and assembly of 
modular biological structures. It requires the use of mechanically and chemically guided 
differentiation of stem cells, with the goal of guiding the emergence of form and function. As a 
research model, development of these biological complex emergent systems can aid by 
addressing the question for the fundamental understanding of the biological design rules from a 
“top-down engineering” approach can potentially elucidate aspects and principles which would 
otherwise be too difficult to isolate from the complex phenomena involved. 
1.2 BACKGROUND 
Engineering of biological machines has been made possible by advances in biofabrication 
techniques. These machines have mostly involved the formation of biohybrid structures 
consisting of undifferentiated muscle cells being differentiated and installed on synthetic soft 
structures that direct actuation towards a design-specific functionality (4). These synthetic soft 
structures serve as scaffolds and have been manufactured through 3D printing of PEGDA, 
molding of PDMS or microfabrication of other such synthetic polymers (3, 5–10).  
In the first generation of bio-machines, differentiated cardiac cells were effectively used as 
actuators, due to their spontaneous development of strong contractions (11). Furthermore, this 
initial biofabrication approach involved forming 2D sheets of differentiated muscle cells directly 
on soft polymer structures which bend when the cardiac muscle’s contractile forces are exerted 
directly on the polymer surface. In order to enhance experimental control on these biohybrid 
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systems, cardiac tissue was substituted with skeletal muscle, which contract only when globally 
stimulated. Furthermore, they have the added benefit of being able to interact with motor 
neurons, thus allowing for more advanced emergent behaviors to be recapitulated and 
engineered. This approach evolved greatly when it was discovered that cells embedded in a 
hydrogel would exert tactile forces on the soft surrounding environment, resulting in a 
compaction of the hydrogel-cell construct (12). This compaction would then permit the cell-cell 
interactions that enable myoblasts to fuse and differentiate into functional (i.e. contracting) 
myotubes.  
This discovery has sparked numerous studies revolving the formation of 3D muscle 
constructs and has enabled the development of the biological robot, or bio-bot. It is composed of 
a 3D skeletal muscle tissue fitted around a 3D printed skeleton that is capable of walking due to 
the actuation of the muscle (13). This model has thus served as an experimental platform for the 
study and engineering of higher order functionalities of biological machines.  
1.3 THESIS OVERVIEW 
This dissertation is divided into three main chapters discussing improvements in 
biofabrication methodology for the engineering of in-vitro biological machines, represented on 
Figure 1-1 as a deconstruction of the approach towards specifically achieving biological 
machines actuated by muscle, driven by programmed neural signals.  
The Chapter 2 proposes the integration of stimulus during the differentiation of motor 
neurons as a tool to enhance network responsivity to the stimulus after network formation. 
Furthermore, the chapter explores the resulting modulation of the neural network’s electrical 
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activity’s frequency profile when the stimulation during differentiation is coupled with 
stimulation during network formation.  
The Chapter 3 presents the development of a protocol to enable the biofabrication of neural 
tissue. This will facilitate the integration processing capabilities of neurons to a diversity of 
experimental platforms, thus expanding the experimental freedom in neural related research 
design. The chapter first discusses the effects of cell concentration on tissue compaction and 
development and then proceeds to characterize the development of neural populations within the 
tissue with respect to intact 3D MEBs and well as its electrophysiological activity and 
interconnectivity. Furthermore, this chapter discusses the implementation of this protocol for the 
formation of human-derived engineered neural tissues. 
The Chapter 4 proposes a redesign of the skeletal muscle-based biobot, by optimizing the 
process of modeling new structures which, through collaborative efforts, use predictive 
computational models that incorporate the inter-dynamics of muscle-to-scaffold. This new 
design algorithm used empirical biological data to propose a new design model to fabricate a 
larger and in turn stronger biobot, in order to facilitate the integration of motor neuronal tissues. 
This empirical data was then used to calibrate the computational model, to open the door for the 
efficient design of next generation muscle-driven biological machines. 
The fifth and final chapters summarizes the findings in the context of the motivation and the 
field’s state of the art. Furthermore, it discusses the applicability of this research to keep 
expanding the field in the realization of these engineered multi-cellular living systems, by 
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proposing next logical steps in this research as well as some exploratory ideas that could enhance 
the functionalities achieved in these findings. Finally, the chapter closes with closing remarks 
regarding the author’s perspective on this quickly growing field of engineering biological 
machines through the combination of biomimicry and forward-engineering. 
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1.4 FIGURE 
Figure 1-1. Engineering a motor neuronal driven biological machine requires various decoupled 
efforts. Previous works have developed a muscle-based platform. Presently there is a need to 
develop tools to be able to program and reconfigure neural sources to drive muscle actuation in a 
design specific fashion while also facilitating the assembly of the neural source on the muscle. 
Furthermore, optimizing the muscle-to-scaffold design would allow for more efficient transfer of 
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CHAPTER 2:  MODULATING ELECTROPHYSIOLOGY OF 
MOTOR NEURAL NETWORKS VIA OPTOGENETIC 
STIMULATION DURING NEUROGENESIS AND 
SYNAPTOGENESIS1 
2.1 INTRODUCTION 
Inducing neuronal plasticity is one of the grand challenges in neuroengineering. 
Understanding and controlling nerve connectivity and their plasticity could have profound impacts 
in regenerative medicine (1–4), as studies have shown that engrafting Motor neuron containing 
Embryoid Bodies (MEBs) can improve recovery in motor nerve injuries(1, 3). The ability to 
enhance or control the electrophysiological functions of such MEBs could be used for 
improvement of motor function recovery. Furthermore, in the emerging field of engineering 
biohybrid neuronal-driven biological machines, it would be highly advantageous to forward-
engineer programmable neural networks that could be installed within in vivo or in vitro systems 
in order to achieve targeted functional behaviors (5–7). While the mechanisms responsible for 
synaptic modulation and circuitry formation (i.e. memory and learning) have been studied in 
invertebrate and mammals, the complexity of neuronal plasticity pathways, such as potentiation 
and homeostatic plasticity, have made it difficult to control neural circuit development for in vitro 
applications (8). Furthermore, studies have shown varying degrees of emerging phenomena that 
1 This work is a reproduction of the following first authored journal article: 
Gelson J. Pagán-Díaz,  Jenny Drnevich, Karla P. Ramos-Cruz, Richard Sam, Parijat Sengupta, Rashid Bashir. 
Modulating behavior of motor neural networks via optogenetic stimulation during neurogenesis and synaptogenesis. 
Scientific Reports. 2019 (In revision) 
Author Contributions:  G.J.P.-D. performed the design, data acquisition and analysis, and writing of the manuscript; 
J.D. contributed by analyzing the RNA Sequencing data; K.P.R. and R.S. contributed with data acquisition and
analysis; P.S. contributed to the conception, design of experiments, and editing of this manuscript.; R.B. led the
project, the conception and design of experiments, contributed to data analysis, and edited the manuscript.
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are correlated to neuronal plastic events that would imply “learning” or “memory storage” in neural 
circuits.(9–13) These varying degrees extend from neural mechanisms that regulate potentiation 
to feedback mechanisms with respect to associations to stimulation. Currently, in vitro micro 
electrode array (MEA) systems have aimed to study the effects of stimulation protocols in the 
resulting network dynamics for the past 30 years (13–19). While some of these studies have 
induced transient changes in the recorded signals, most have focused on changes of number of 
action potentials in mature primary neurons and in learning as a result of feedback to strengthen 
associations to the stimulation patterns. Due to the fact that these phenomena emerge from the 
multiple endogenous neuronal plasticity pathways, finding new approaches to enhance and 
modulate these plastic responses in a long-term way would be highly advantageous in the field.  
Because most of these studies on plasticity have focused on modulation of mature neurons, we 
hypothesized that we could induce plasticity-related long-term electrophysiological changes in in-
vitro neural networks, by implementing training regimens during early stages of differentiation, 
i.e. neurogenesis, coupled with training regimens during network formation, i.e. synaptogenesis.
To this end, we used 465 nm pulsed light to induce depolarization in specific temporal patterns to 
implement a training regimen on differentiating channelrhodopsin (ChR2)-expressing motor 
neuronal embryoid bodies (MEBs) grown in suspension and continued the training regimen after 
seeding them on functionalized glass to allow for neurite extension and network development. In 
parallel, we seeded the MEBs on MEA chips while continuing training regimens to be able to 
characterize the network dynamics during network development. We first characterized responses 
to the optogenetic stimulation during neurogenesis by assessing morphological parameters, 
followed by analyzing the resulting electrophysiological responses including the network’s 
synchronicity, firing patterns in power spectra and the system’s responsivity to stimulation during 
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recording. These results showed a direct correlation between perturbations during differentiation 
and plastic responses occurring during network formation.  Finally, through RNA sequencing 
studies, we observed genetic changes that serve to explain the observed modulations in these 
neuronal systems. 
2.2 MATERIAL AND METHODS 
2.2.1 MESC CULTURE AND DIFFERENTIATION 
A feeder layer of myocin-C inactivated mouse embryonic fibroblast (MEF) was seeded at a 
cell density of ~3.5 x104 cells/cm2 and cultured in DMEM (Dulbecco’s modified Eagle’s medium) 
supplemented with 1% fetal bovine serum, 1% L-glutamine and 1% penicillin-streptavidin. 
Subsequently, HB9:GFP transgenic mouse embryonic stem (mES) cells transfected with 
(Channelrhodopsin) ChR2-TdTomato were seeded on the feeder layer (mESC at a ratio of 1.5 mES 
cells per MEF. Media was changed to mESC proliferation medium and replaced daily. 
Differentiation begun prior to mESC colonies coming in contact with one another. Cultures 
were trypsinized (0.05% Trypsin) after being exposed to embryonic stem cell differentiation 
medium (eDM) for an hour, and later seeded on 100 mL low adhesion dishes in 10 mL eDM. The 
next day, floating cells were collected to separate the culture from adhered non-neuronal lineages. 
On the following day, embryoid bodies (EBs) were replated in eDM supplemented with 1µM of 
retinoic acid (RA) (Sigma Aldrich, MA) and 1µM puromorphine (PM) (STEMCELL 
Technologies, MA). On D5, EBs were resuspended in eDM supplemented with RA and PM plus 
10 ng/mL of growth factors, glial cell-derived neurotrophic factor (GDNF) and ciliary 
neurotrophic factor (CNTF) respectively. Media was changed daily.  
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2.2.2 MEA FABRICATION 
Platinum micro-electrode array chip were fabricated on borofloat glass wafers following 
standard lithographic techniques. Photoresist LOR3A (MicroChem, MA, USA) was spun on clean 
substrates, followed by spin coated layer of photoactive S1805 (Dow Chemical Comp., MI). Spun 
substrates were exposed using an EVG 620 (i-line) aligner (EV Group Inc., Tempe, AZ) and 
developed. Ti/Pt (1:3) was later evaporated for a total thickness of 1000 Angstroms. To passivate 
traces between the detection area and contact pads, 300 nm of silicon nitride was deposited on the 
entire substrate using Plasma-Enhanced Chemical Vapor Deposition System (PlasmaLab 
International, WA). Finished chips were diced into 49 x 49 mm squares and fitted with acrylic 
wells bonded by Dow Corning Sylgard 184 (Ellsworth Adhesives, IL). 
To ensure that thermally generated noise voltages were below membrane voltage fluctuations 
during neuronal electrical activity, electrode impedance was decreased through electrochemical 
treatment of the electrodes (21). Platinum black was formed on top of clean electrodes to achieve 
high surface area using a Gamry Reference 600 Potentiostat. The galvanostatic deposition was 
achieved by running a chronopotentiometry experiment at 2.83E-6 A/cm2 vs. Ag/AgCl for 15 
seconds in a solution of dihydrogen hexachloroplatinate (0.08 mM H2PtCl6-6H2O, Sigma Aldrich, 
with 0.25 g/L of (CH3COO)2Pb Alfa Aesar) for a total of 21.45 ng (1.71E-2 ng/µm
2) of crystallized 
platinum. The impedance reduction due to the platinum black deposition was examined by 
electrochemical impedance spectroscopy. 
2.2.3 ELECTROPHYSIOLOGY RECORDING 
MEA measurements were performed using a MEA 2100-Lite Amplifier (Multi Channel 
Systems MCS GmbH, Germany) at 37oC. Electrical activity from ChR2+ MEBs cultured on MEA 
13 
were measured every other day. Measurements were performed in dark at a sampling rate of 10 
kHz for 20 minutes in FS eDM with sealed covers to keep CO2 concentration stable. 
Optogenetic stimulation was performed using LED Driver (Doric Lenses, Quebec, Canada) 
attached to a single LED, Blue 465 nm with a Fiberoptic Patchcord for an incident intensity of 10 
mW/mm2 (Figure 2-1). Stimulation patterns were designed with Doric Neuroscience Studio. 
Optogenetic potentiation regimens were performed in a 3D printed casing which held the fiberoptic 
in place against the dish lid. During neurogenesis, stimulation was achieved by collecting MEBs 
and resuspending in a 35mm dish which fit in the 3D printed casing. During recording, stimulation 
was done by mechanically holding the fiberoptic against the MEA lid. Potentiation regimens 
consisted of 5ms pulses at 20Hz for one second every other second for 1 hour for a total of 1800 
cycles, while stimulation during recording consisted of the same pattern for only 10 cycles at 
equidistant times during the 20 minutes recording sessions. Measurements and calculations of heat 
transfer from beam to the media showed that the energy imparted would cause temperature 
fluctuations of less than 1oC, which are less than fluctuations from normal cell handling. 
2.2.4 CRYO-SECTIONING
For phenotypic counting, EBs were sectioned and stained using adapted published 
protocols.(22) At D9, 20 EBs were sampled and fixed for 20 minutes in 4% paraformaldehyde. 
After washing with PBS, buffer was sequentially substituted with sucrose solutions (10% w/v, 
20% w/v and 30% w/v). After an overnight wash at 30% w/v sucrose solution in 4oC, EBs were 
embedded in OCT solution (Tissue-Tek, CA) and frozen on dry ice prior to storing in -20oC. Molds 
were sectioned in 20µm thick layers unto SuperFrost Plus slides (ThermoFisher Scientific, MA) 
and air dried at room temperature for 1hr and followed by staining. 
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2.2.5 IMMUNOSTAINING AND IMAGING 
Immunocytochemistry was performed on samples fixed with 4% paraformaldehyde and 
treated with 0.05% Triton-X. Permeabilized samples with blocked with 4% bovine serum albumin 
at 4oC overnight. Samples were later stained with primary antibodies at 4oC overnight, followed 
by staining of secondary antibodies at room temperature for 2 hrs. All antibodies were diluted in 
Antibody Diluent (ThermoFisher Scientific, MA). For phenotype quantification, MEBs were 
embedded in OCT solution and sectioned prior to staining. The used antibodies were 1) anti-NeuN 
antibody for neural populations, (clone A60, Alexa Fluor 555 conjugate), 2) anti-glial fibrillary 
acidic protein antibody for astrocyte populations, (clone GA5), 3) anti-oligodendrocyte 
transcription factor 2 protein antibody for oligodendrocyte populations, 4) anti-adenosine A2A 
receptor protein antibody for excitatory populations, 5) anti-parvalbumin protein antibody for 
inhibitory populations  and 6) DAPI as a nuclear stain. For synaptophysin clustering quantification 
between MEBs, the used primary antibody was anti-synaptophysin 1 polyclonal chicken antibody 
(Synaptic Systems, Germany). It was counter stained with goat anti-chicken IgY AlexaFluor 647 
(Abcam, MA), respectively, along with DAPI as a nuclear stain. After washing overnight at 4oC 
in blocking buffer, samples were mounted with Prolong Diamond antifade (ThermoFisher, MA) 
and imaged using Zeiss 880 Confocal microscope (Carl Zeiss Microscopy). 
2.2.6 SCANNING ELECTRON MICROGRAPHS 
SEM images were taken at 1kV after grounding the entire array through the contact pads, to 
avoid charging the insulating Nitride layer, at 100-300X magnification. 
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2.2.7 RNA EXTRACTION 
Samples of MEBs were carefully collected and centrifuged at 14000 rpm for 15 minutes. 
After aspirating supernatant, samples were flash frozen using liquid nitrogen and immediately 
stored at -80°C, until mRNA extraction. Total RNA was collected and purified using the RNeasy 
Mini Kit Part 1 (Qiagen). The total RNA concentration was quantified using a Nanodrop 
spectrophotometer.  
2.2.8 QUANTIFICATION AND STATISTICAL ANALYSIS 
2.2.8.1 Spike/burst analysis  
Multi-Channel Analyzer software was used for counting and analytically extracting temporal 
parameters of fast events. Raw data was digitally filtered using a 2nd Order Butterworth high pass 
filter (cutoff frequency: 200 Hz). Action Potentials (APs), were detected as “spikes” by setting a 
threshold at 5x standard deviations from the noise magnitude distribution. Analysis of firing rate 
behaviors and burst parameters followed spike detection (citation for burst analysis). For this 
experiment, burst detection was defined by the following parameters: 
• Max interval to start burst: 50 ms
• Max interval to end burst: 50 ms
• Min. interval between bursts: 100 ms
• Min. duration of burst: 50 ms
• Min. number of spikes in burst: 4
 This analysis was done for active electrodes which were defined as electrodes which recorded 
at least 10 AP/min.  
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2.2.8.2 Spectral analysis 
Spectral analysis was performed on the slow component of raw data to assess modulations in 
network behavior. Data extracted as ASCII files were filtered in MATLAB using Butterworth 
2nd order high pass digital filter with a cutoff frequency of 200Hz. Spectral components in the 
frequency domain were obtained through Fast Fourier transform (FFT) between 0.1 – 200 Hz to 
remove DC components from data.   
FFT was obtained for subsequent non-overlapping intervals of 10 s across the initial 4 minutes 
of spontaneous activity and normalized by the area under the curve. Calculated spectra 
were smoothed using a 3-point window moving average. Data was stored in 2D matrices, summed 
across electrodes and averaged across MEAs (n=3, mean ± std. dev, 2-tailed T-test). 
2.2.8.3 Synaptophysin cluster counting 
Stack images were superimposed for 10 microns in ImageJ. The Images were zoomed until 5-
10 saturated pixels for SY38 were clear. Then a binary threshold was set so that only those pixels 
were conserved. Images were sampled ten times at regions between MEBs with a 150-by-150 µm 
area across three biological repeats by day (n=30, mean ± std. dev).  
2.2.8.4 Quantifying network synchronicity 
Overall network correlation was assessed through the automated use of spike data and a 
customized MATLAB code that calculated cross-correlation for discrete functions, as follows: 
(𝑓 ∗ 𝑔)[𝑛] ≝ ∑ 𝑓∗[𝑚]𝑔[𝑚 + 𝑛]
∞
𝑚=−∞
Here, f and g denote the discreet functions at point n, which represent the recorded MEA 
signals. Furthermore, f* denotes the complex conjugate and m is the lag or displacement, meaning 
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a feature in f occurring at n that occurs in g at n+m (23). Spike train data for each channel was 
cross-correlated with every other channel. Results were normalized so the autocorrelations have 
unit value at zero lag. The value at zero lag (tch-x=tch-y) was stored for each correlation in a 60-by-
60 matrix relating every channel to each other and plotted as a heat map and a bar graph was used 
to plot the average. (n=3, mean ± std. dev, 2-tailed T-test). 
2.2.8.5 RNA sequencing analysis 
The RNA-seq libraries were prepared with Illumina's 'TruSeq Stranded mRNA-seq Sample Prep 
kit' (Illumina). The libraries were quantitated by qPCR and sequenced on one lane on a HiSeq 
4000 for 101 cycles from one end of the fragments using a HiSeq 4000 sequencing kit version 1. 
Fastq files were generated and demultiplexed with the bcl2fastq v2.20 Conversion Software 
(Illumina). Adapters and low-quality bases were trimmed from reads using Trimmomatic(24) 
(v0.36) with parameters LEADING:28 TRAILING:28 MINLEN:30. The trimmed reads were 
quasi-mapped to Gencode’s M19 transcriptome using Salmon(25) (v 0.8.2) with additional 
parameters –seqBias --gcBias --numBootstraps=30. Transcript expression value were summarized 
to the gene-level and corrected for average transcript length using the “lengthScaledTPM” 
method(26). TMM-normalized(27) log2 counts per million (cpm) values (prior.count = 3) were 
calculated and only genes with > log2(0.5 cpm) in at least 3 samples were analyzed using the 
limma-trend method(28). Three pairwise comparisons were made (C vs D2, S vs D2 and S vs C) 
and multiple testing correction was done separately for each comparison using the False Discovery 
Rate method(29); significant differential expression was indicated at FDR p-value < 0.05.  
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2.3 RESULTS 
2.3.1 APPROACH TO MODULATION OF MESC DERIVED NEURAL CIRCUITS 
Optogenetic stimulation was used on mESC-derived MEBs to implement training regimens 
during two important stages of neural development: neurogenesis (still in suspension) and 
synaptogenesis (seeded on functionalized glass or MEAs) (Figure 2-2a). Training regimens 
consisted of periodic stimulation with 5 ms pulses at 20 Hz for an hour (Figure 2-1). This regimen 
has been shown to enhance axonal growth (30), and thus would suggest that it could lead to a shift 
in structural potentiation in a neural network. The regimen was repeated every 24hrs as 
differentiation occurred within the EBs, with an expectation that consistent repetition would 
enhance the potentiation and cause long-term changes in the firing patterns of the network. 
Following established differentiation protocols of mESC towards mature motor neurons (31–33), 
the described training regimen was started at D2 of differentiation, at which point stem cells had 
been induced towards neuronal lineages, and specialization and maturation of motor neurons has 
been shown to take place in the subsequent 7 days (Figure 2-2b). Since the transcription factors 
that drove differentiation are light sensitive, media was changed every single day immediately 
after stimulation to ensure that stimulation effects on MEBs were not artifacts (i.e. false positives) 
caused by photodegradation of factors (Figure 2-3). Furthermore, since the differentiation was 
monitored with the expression of the motor neuronal marker Hb9 through a GFP reporter, the 
plateau of GFP expression between D8 and D9 (Figure 2-4), suggested that D9 was an appropriate 
time point for seeding the MEBs on glass. Thus, after these 7 days (D2-D9) of differentiation, 
stimulated (S) and non-stimulated (NS) cultures were seeded on MEA chips (Figure 2-2c). Careful 
seeding practices were applied to ensure that ~20 MEBs were seeded within the sensing area of 
the MEAs for a ~50% coverage by the MEBs (Figure 2-5).  Seeding in this manner ensured empty 
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space between clusters for the extension of processes, even though some nearby clusters would 
start fusing into larger clusters. The resulting two groups of samples seeded on MEAs were further 
subdivided into two more experimental groups, referring to whether or not a training regimen was 
continued during network formation on chip for the consequent 15 days (D10-D25). For ease of 
discussion, S or NS prior to a colon (e.g. S:X or NS:X) will refer to the presence or lack thereof of 
stimulation, during neurogenesis, while S or NS written after a colon (e.g. X:S or X:NS), will 
indicate the presence or absence of stimulation during synaptogenesis (Figure 2-2a).  
The electrical activity of the resulting neuronal cultures was measured with the MEA system 
and the raw data was filtered to remove low frequencies (<200Hz), to remove undesired voltage 
artifacts (e.g. stimulation artifacts), and extract action potentials recorded as spiking events (Figure 
2-2d). A two-step procedure was used to remove false positives from the analyzed data: 1) the
detection threshold was set so that it would not detect any spikes from the ground electrode, then 
2) the recorded spikes at each electrode were inspected to ensure that the detected spikes had the
appropriate voltage phases relating to action potentials: depolarization, depolarization and 
refractory period.  
2.3.2 MEB CULTURES FORM ACTIVE NEURAL NETWORKS WITH EXCITATORY AND 
INHIBITORY POPULATIONS 
In this work, neural networks were cultured from intact MEBs, in contrast to growing them 
as a monolayer after dissociation. The long-term goal of our study is the modulation of electrical 
activity of the MEBs with the goal of installing in-vivo or in-vitro experimental systems and 
modulating the functionality of the resulting interactions (Figure 2-4). When cultured in their 
intact form, MEBs tend to keep their spheroid shape, while extending membrane dense processes 
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which contain neurites that form networks as they undergo synaptogenesis (Figure 2-6a). 
Furthermore, dense web-like neurite structures form within the spheroid itself (Figure 2-6b) and 
positively stained for both excitatory (vGlut) and inhibitory (GAD65/67) receptors (Figure 2-6c).  
Network formation was validated by exposing MEB cultures grown on MEAs (Figure 2-6d) 
to varying concentrations of commonly used exciting and inhibiting signaling molecules: L-
glutamate, acetylcholine, cyclic AMP, cyclic GMP, GABA, norepinephrine etc. (Figure 2-6e). 
As expected, L-glutamate evoked an excitatory response to the point of cytotoxicity beyond 100 
µM, while other excitatory neurotransmitters, acetylcholine and cyclic AMP, continued a gradual 
increase in firing rate with increasing concentrations. Cyclic GMP, another cyclic nucleotide 
similar in function as cAMP, failed to evoke any significant effect on firing rate. On the other 
hand, inhibitory neurotransmitters norepinephrine and GABA showed a gradual decrease in 
firing rates. The responses corroborated the development of endogenously active neural networks 
expressing different kinds of receptors. The observations that MEBs extend processes within the 
body itself while responding to both excitatory and inhibitory signaling molecules could led to 
the hypothesis that these MEBs could be forming intrabody circuits which could be “trained” 
during differentiation and have these changes last after network formation.  
2.3.3 STIMULATION DURING NEUROGENESIS RESULTS IN MORPHOLOGICAL 
CHANGES IN MEB CULTURES 
The effects of stimulation during differentiation were initially observed in neurite extension 
and presynaptic protein clustering. While it has been reported that neurite outgrowth would be 
enhanced if neural populations simultaneously underwent optogenetic stimulation (30), it was 
not clear if effects of the stimulation on MEBs done in suspension would still result in an 
increase in neurite extension when later seeded on chips, as this would indicate some stable long-
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term changes in the neuronal system. To quantify this, S:NS and NS:NS MEBs were seeded at 
low confluence on gridded coverslips and imaged at 6 times every two hours on D10 (1 DIV) to 
quantify the number of extending neurites (Figure 2-7a). Observations showed a statistically 
relevant increase of number of neurites extended for S:NS samples, compared to NS:NS, which 
indicates an increased rate of neurite extension as a result of the stimulation during neurogenesis 
(Figure 2-7b). Next, we wanted to observe the effect of stimulation during differentiation on the 
propensity of the network to form synapses. To quantify this, the clustering of presynaptic 
synaptophysin stained with anti-SY38, was counted along individual neurites as well as per unit 
area between the groups NS:NS and S:S  (Figure 2-7c). By D11 (2 DIV) S:S samples showed a 
~2-fold increase of synaptophysin clusters per neurite than NS:NS samples (Figure 2-7d). This 
increase of pre-synaptic clusters per neurite combined with the increase in neurite extension, 
resulted in ~3-fold increase of synaptophysin clusters per unit area at D11 (Figure 2-7e). When 
monitoring the difference of pre-synaptic clusters per unit area at D13 and D15, the significant 
difference indicated that optogenetic stimulation during neurogenesis evoked physiological 
responses on two important aspects of neural network development: neurite extension and 
presynaptic clustering (Figure 2-7e). 
2.3.4 MEB NETWORK SYNCHRONICITY IS AMPLIFIED BY STIMULATION DURING 
NEUROGENESIS AND SYNAPTOGENESIS 
Network synchrony is a common parameter used to characterize a developing neural 
network, as it gives information on the network’s plasticity and connectivity. Various studies 
have successfully shown that the presence of chronic stimulation results in improved network 
synchrony (34–36). In our study, we wanted to observe the long-term effects of stimulation 
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regimens on the network synchrony and determine if these effects were amplified or shifted 
when the training regimen during neurogenesis was extended during synaptogenesis. From the 
raster plots of the spontaneous activity recorded at D21, the increased level of synchronous 
activity was notable between NS:S and S:S samples versus S:NS and NS:NS (Figure 2-8a). This 
can be appreciated by the peaks above the raster plots, which correspond to a summation of the 
activity across all electrodes, where synchronous networks would result in discrete peaks 
whereas in samples that lacked coordinated firing, the resulting line plot seemed to lack any 
peaks.  
Similarity between electrode recordings was characterized with cross-correlation in order to 
quantify synchronous behavior. Values for the similarity across the network were obtained by 
calculating cross-correlation for all electrode combinations (Figure 2-9). For this analysis, only 
spontaneous recording of active electrodes was used to quantify the long-term effects of the 
training regimen on steady state synchrony. When average correlation values per electrodes were 
mapped to their position on the chip, NS:S and S:S samples showed high synchrony level across 
the entire network for spontaneous recordings at D21 (Figure 2-8b). This showed that 
synchronous behavior extended across the entire network and was markedly higher for networks 
that were stimulated during synaptogenesis.  
Interestingly, when the network wide mean synchronicity was calculated for each recording 
day, synchrony was higher for the samples that were stimulated during neurogenesis for the first 
two recordings at D11 and D13, yet for later recordings only the samples that continued with the 
training regimens during synaptogenesis (NS:S and S:S) maintained the observed increase of 
synchronicity (Figure 2-8c).  
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2.3.5 SPECTRAL DENSITY ELUCIDATES CHANGES IN STEADY STATE FIRING 
Conventionally, electrophysiological behavior is characterized by firing rate during set 
epochs and burst parameters (Figure 2-10). However, when analyzing these parameters during 
spontaneous firing, there was no discernable trend in the change of long-term firing rate or burst 
parameters between experimental groups. However, when observing the high pass filtered 
recorded data during steady state on D25, there were deviations on how the firing is structured, 
despite the fact that no clear change in the amount of activity was observed (Figure 2-11a). We 
accredited this seeming conflict between the quantitative and qualitative data to the burst 
detection parameters. In order to avoid arbitrariness in the selection of these parameters, we 
decided to characterize the data in the frequency domain. For this reason, we focused on 
characterizing spontaneous firing recorded on MEAs by comparing changes in the power 
spectrums of recorded signals calculated through Fourier transforms (Figure 2-11b). To obtain 
spectral profiles, the recorded data was divided into 10-second-long contiguous windows and 
transformed to the frequency domain, thus representing the power spectrum as a function of time 
(Figure 2-11b). Focusing between 0.1-5 Hz, all samples except S:S, showed firing patterns that 
seemed to be more or less random. This spontaneous heterogeneous firing patterns can be 
expected from these cultures formed from MEBs, as they are a super-network composed of 
individual networks from within each MEB. On the other hand, S:S samples show a clear change 
in their frequency profile, where most of the spectral power fell within 0.1-1Hz. 
An interesting point to note is that if the signal power is summed across the entire frequency 
range of interest, there is no difference between samples on any particular day (Figure 2-12). 
However, if the signal power is summed between the frequency range of 0.1-1Hz, there is a 
significant change between non stimulated during synaptogenesis (NS:NS, S:NS, NS:S) and 
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stimulated throughout development (S:S) (Figure 2-11c). Moreover, there is also a significant 
difference between NS:S, and S:S, which indicated that combined stimulation of both 
neurogenesis and synaptogenesis had an amplified effect than just stimulation during 
synaptogenesis. 
2.3.6 NEUROGENETIC STIMULATION CHANGES THE OPTO-RESPONSE OF MEB 
NETWORKS 
Another aspect of consideration on the effect of training MEBs during neurogenesis was 
whether the early stage perturbation has some effects on how the later-stage network would 
responds to the same perturbation. To study this, we recorded responses to optogenetic 
stimulation from sets of samples that had not undergone the training regimen during 
neurogenesis (Figure 2-13a), and compared them to those set that had undergone such regimen 
(Figure 2-13b).  Initial observation showed a difference between how the networks responded 
when stimulated early in the network development (D11) versus more mature networks (D25). 
For example, when early networks, which had a low spontaneous firing rate (D11) were 
stimulated, there would be a very notable evoked response during stimulation followed by a 
quiescent state, where the network would barely fire before returning to the baseline spontaneous 
firing rate. In contrast, more mature networks (D25), would still show and evoked response 
during stimulation but would automatically return to baseline firing rate right after stimulation 
ceased. What was interesting was that the quiescent time after stimulation that early S:S 
networks would show, were notable shorter than those from  the NS:S samples (Figure 2-13a-b). 
Moreover, at D25, while NS:S samples would return to the same baseline firing rate right after 
stimulation stopped, S:S samples showed a transient change in firing rate for several seconds 
after the stimulation stopped (Figure 2-13a-b). To quantify this behavior, the evoked firing rate 
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during stimulation (FRstim) and the post-response firing rate (FRpost) was compared to the firing 
rate prior to stimulation (FRpre) (Figure 2-13c). While the fold-change increase of firing rate 
FRpre  to FRstim decreased with time, since more mature networks would have a higher baseline 
firing rate, when comparing the amount of evoked action potentials during stimulation 
(FRstim/FRpre), for all days of recording, S:S samples consistently responded more strongly to 
stimulation than NS:S samples (Figure 2-13d). Furthermore, the quiescent state response post-
stimulation observed in early days (D11), reflected itself in FRpost being less than FRpre. 
Nevertheless, this lag was shorter for the S:S samples than the NS:S, as evidenced by a 
significant increase in the S:S cohort’s FRpost/FRpre ratio (Figure 2-13e). Furthermore, at later 
days of network development, it was notable that FRpost/FRpre was ~1 for NS:S, meaning that the 
steady state firing rate was indistinguishable from that immediately following the termination of 
stimulation. On the other hand, S:S samples showed FRpost/FRpre values above 1 from D17 
forwarding, indicating that the network would transiently increase in firing rate right after 
stimulation.  
To further study how the training regimens affected network response, we also quantified the 
evoked response reflected in the network’s synchronicity.  For this purpose, raster-plots of the 
average values of cross-correlation (as calculated for the analysis in Figure 2-8) were calculated 
using 10 second bins across the entire 20 minutes of recording (Figure 2-13f). This showed that 
for NS:S samples, the network wide synchronicity did not respond consistently among the 
different days of recording, however for S:S samples (samples that underwent training regimen 
during neurogenesis as well) consistently showed transient increase in network synchronicity 
right after stimulation was implemented (Figure 2-13g). 
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2.3.7 CHANGES EVOKED BY STIMULATION DURING NEUROGENESIS RESULT IN 
GENETIC CHANGES 
Given the effects on neurite extension, presynaptic clustering, frequency profiles and 
network response to stimulation that were observed as a result of the presence of training 
regimens on MEBs during neurogenesis, we proceeded to determine genetic changes that could 
provide possible mechanistic explanations. Total messenger RNA sequencing was performed 
and analyzed for stimulated (S) and non-stimulated (NS) MEBs at D9, as well as EBs at D2. The 
differentially expressed genes in MEBs that underwent training regimens during neurogenesis 
were compared to those that did not, both with respect to the genetic expression of MEBs 
sampled prior to differentiation (at D2). A total of 749 differentially expressed genes between S 
and NS with p < 0.05 were detected and clustered and color coded with respect to the differential 
expression of D2 (Figure 2-14a). There were 200 genes that were upregulated during control 
differentiation, but this upregulation was lessened for samples that underwent training regimen 
(black bar), while the upregulation of 172 genes was amplified for those same samples (red bar). 
On the other hand, there were 202 genes whose downregulation was stagnated for samples with 
training regimen (yellow bar). For 173 genes, the control downregulation was further amplified 
after stimulation (blue bar). Something important to note was that this observed differential 
expression did not include changes in phenotype populations, matching the immunostaining 
observations (Figure 2-15). This indicated that training regimen during differentiation did not 
seem to noticeably disrupt the rate of phenotype specification or generation of the neural 
populations that generally result from the differentiation protocol (Table 1).  This suggests that 
training regimens affected other functional pathways rather than altering the differentiation of 
populations. For further analysis, a more stringent threshold (p<0.0005) was set to detect the 
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most promising genes as key factors for the behavioral changes seen in stimulated MEB cultures. 
This threshold resulted in 97 differentially expressed genes for the black cluster (Figure 2-14b), 
63 differentially expressed genes for the red cluster (Figure 2-14c), 77 differentially expressed 
genes for the yellow cluster (Figure 2-14d) and 71 differentially expressed genes for the blue 
cluster (Figure 2-14e). From this pool, a thorough literature study was used to identify gene 
targets that had been reported to be related to known neural development and function (Table 2, 
Figure 2-16). 
2.4 DISCUSSION 
Engineering of neural circuits is a critical step for biomedicine as well as various 
neuroengineering efforts. This work aimed to expand upon previous findings on achieving long 
term modulation of a neural network’s behavior.(10, 13, 16, 37–40). Here, we showed a direct 
relation between changes in network function and development and training regimens 
implemented during neurogenesis and synaptogenesis. To our knowledge there has been no 
electrophysiological characterization of mESC-derived neural networks’ electrical response 
where a relationship between training during neurogenesis and synaptogenesis is examined. 
Furthermore, these effects were correlated and supported by RNA-seq studies, where we showed 
that the training regimen affected targets related to network development, rather than affecting 
the differentiation of neural populations. In mESC-derived embryoid bodies, stimulation during 
neurogenesis has shown that the system enters a heightened state for neurite extension, which 
could be correlated to enhanced network formation. Furthermore, our study suggests that the 
presence of stimulation during neurogenesis has caused the system to be more sensitive and 
responsive to external stimulation after network formation, which could have implications on 
research studies where MEBs are integrated in in-vivo nerve tissues that have suffered injury. By 
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implanting “trained” MEBs that have an enhanced responsiveness to stimulation, the therapeutic 
effects that have been observed could in turn be enhanced as well. (3) 
Furthermore, spectral analysis proved to be a useful tool in order to quantify changes in 
network behavior that might be missed by simply comparing firing rates. While firing rate did 
not clearly reflect any alteration to the steady state, transforming the electrical signal to the 
frequency domain served as an informative descriptor of alterations in the network dynamics as a 
result of the training regimens. Using FFT to characterize the network’s firing patterns as a 
response to the training regimens during network formation complements various other network 
effects that have been observed in this study. Because consistent evoked firing will accelerate the 
potentiation of preferred synapses, it follows that the system will reach a higher level of 
synchrony which in turn suggest structured firing, as synchronous behavior would be more 
viable in a structured versus a sporadically firing network.  
Another very notable observation was that training regimen during neurogenesis evoked 
changes in the way the system would respond to the same stimulation after the network had 
formed. During early culture on chip (D11-D15), stimulation would cause the system to enter a 
quiescent state following the forced state of rapid firing from the stimulation, yet this quiescent 
state was significantly shortened for samples that had been stimulated during neurogenesis. 
Moreover, these distinctions extended beyond early stages of network formation, which also 
manifested as prolonged transient increases of network synchrony. This is relevant because, 
while tetanic stimulation has been correlated to potentiation, no change in baseline firing rate 
was observed. Therefore, if no long-term changes had been caused by training regimen during 
neurogenesis, there should have been no reason for the optogenetically evoked firing rate on chip 
to have shown any differences to the NS:S counterparts. This enhancement of response in 
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samples that were subjected to a controlled perturbation during neurogenesis points to long-term 
systematic changes due to training regimen.  
To further validate these observations, RNA sequencing was performed on MEBs showing 
that a large number of genes were found to have been differentially expressed as a result of the 
training regimen. To focus our findings, the search was narrowed to genes showing a fold change 
with p<0.0005 and key genes related to neural function were selected. Upon observation of this 
narrowed list, we found that following training regimen during neurogenesis the expression of 
key developmental genes Npdc1 and Crabp2 more closely resembles that of more mature tissue. 
Other differentially expressed genes implied an improved development of key neural aspects 
such as axonal and dendritic growth (Tuba1a) and nucleation of microtubules (Tubgcp4). 
Furthermore, stimulated MEBs seems to overexpress important factors related to vesicular 
signaling such as Snap47, Vamp2, Reep2, and more importantly Cacng7. More importantly, 
various genes are directly related to improved synaptic function and plasticity. For example, 
upregulation of Aplp1, Cnih2 and Insyn1 would be targets of interest that could account for the 
structured firing patterns and the changes in the network responses to evoked stimulation.  
Considering the change in expression of these genes related to vesicle transport, synaptic 
transmission and neural development, the observations of shorter quiescent times post-
stimulation for samples that underwent training regimens could suggest that the training regimen 
enhanced the network for a quicker recovery from synaptic fatigue, which is an activity-
dependent temporary inability of neurons to transmit signals(41).  Moreover, it is worth noting 
that Cnih2 and Insyn1 are regulators of inhibitory signaling related to the slowing down of signal 
transmission to improve its reliability, yet a lot is unknown about how these targets affect larger 
scale pathways and neuronal function. While neuronal networks have gene expressions which 
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parametrize the range of functionality of a resulting circuit, little is understood about how a set 
point is determined and how to controllably shift that point. By continuing plasticity studies that 
target all stages of neural development and coupling them with genetic signatures, these 
questions might be better addressed. Moreover, expanding this study to obtain protocol-specific 
responses in gene expression would be crucial in understanding neural plasticity and learning 
mechanisms.  
Nevertheless, the results presented in this study add a new dimension to neural circuit 
engineering, by taking advantage of the synergy between responses to stimulation during 
differentiation and the plasticity that emerges during network formation, and correlation to gene 
expression. This solidifies our initial hypothesis that implementing training regimens during 
early stages of neural circuit development should be considered as a critical factor for studying 
neural plastic phenomena. In order to further this study, improved training regimens and spatial 
stimulation patterns during neurogenesis and synaptogenesis could be used to further the 
characterization of the network response. Furthermore, this approach could be expanded to in-
vivo systems in order to examine if these alterations in fact result in behavioral changes in a 
developing organism and if the enhancement of mESC-derived MEBs result in regeneration 
studies by enhancement recovery of nerve tissue injury.  
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2.5 FIGURES AND TABLES
Figure 2-1. Light intensity measurements of the optogenetic 465nm laser as a function of the 
current. (blue region denotes adequate intensity to elicit a response from ChR2) 
32 
 Figure 2-2 Approach to training mESC-derived motor neuronal embryoid body networks during 
neurogenesis and synaptogenesis. a Representative diagram of experimental setup combining 
differentiating ChR2 mESC’s and MEAs. b Representative diagram of ChR2 mESC 
differentiation toward motor neuronal embryoid bodies monitored by the expression of GFP, 
guided by the motor neuronal specific Hb9 promoter (scale bar: 200 µm). c Representative image 
of fabricated MEA chip. d Representative spontaneous spike trains from MEA recordings of 
cultured embryoid body networks.  
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Figure 2-3. a Stimulation regimen for differentiating and on chip samples. b Feeding regimen for 
samples 
34 
Figure 2-4. a Bar graph showing daily increase of HB9::GFP fluorescence during neurogenesis, 
normalized by the area of the embryoid bodies (n=20, mean ± std). b Box plots describing daily 
change in embryoid body diameter (n=20, perc. 25,75). c Representative image of MEB 2DIV 
seeded on laminin-coated glass. (Scale bar: 200 µm) 
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Figure 2-5 a. Average coverage of MEBs on the MEA sensing area between groups (n=3, 
mean± std). 
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Figure 2-6. Intact MEBs indicate formation of internal networks and form active networks 
between them a i) Scanning electron micrograph of two embryoid bodies. (scale bar: 200 µm) 
and ii) confocal image showing dense clusters of synaptophysin between cultured embryoid 
bodies (scale bar: 50 µm). b i) MEB cryosections showing usual internal structure. (Scale bar: 50 
µm) with ii) zoom in of internal structure of a sectioned embryoid body (scale bar: 15 µm). c 
Representative confocal image of MEB cryosection stained for GAD65/67 and vGlut. Triangles 
show GAD65/67 clusters   d . Representative confocal image of entire field of view for neural 
culture grown on the MEA sensing area (scale bar: 200 µm) with scanning electron micrograph 
zoom in of embryoid bodies extending processes atop of sensing electrodes. e. Bar graph for 
average firing rate for consecutive 10 s windows for cultured embryoid body networks exposed 
to known neuronal signaling molecules at sequential addition of tonic baths of 10, 100 and 250 
µM. (Glut: Glutamate; ACh: Acetylcholine; cAMP: cyclic AMP; cGMP: cyclic GMP; NE: 
norepinephrine; GABA: gamma-aminobutyric acid).(n=15, mean ± std). (* p<0.05; ANOVA 
with Tukey Post-hoc) 
37 
 Figure 2-7. Stimulation during neurogenesis affects key morphological parameters of network 
formation. a. Representative phase contract images of neurite extension along the periphery of 
embryoid bodies between non-stimulated (NS) and stimulated during neurogenesis (S) samples 
(scale bar: 50 µm). b. Box plot quantifying the number of neurites protruding from the periphery 
of an embryoid body per length of the perimeter of the embryoid body for the second half of the 
first 24hrs after seeding (n=10). c. Representative fluorescence images of SY38 clustering at D11 
along a neurite. Arrow denote SY38 clusters. (scale bar: 5 µm). d. Box plots of SY38 clusters 
along neurites for D11 (n=10). e. Box plots of SY38 clusters per unit area for D11-D15 (n=10) 
(*p<0.05, **p<0.0005, ***p<10-5 ; two-tailed T-test). 
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Figure 2-8. MEB network synchronicity is amplified by stimulation during neurogenesis and 
synaptogenesis.  a. Representative rasterplots of MEB cultures at D25 showing network 
synchrony by line plots of the sum of active electrodes for each time point. b. The average 
correlation value (χ) was calculated for each electrode across time and active electrodes for a 
average value for each electrode, then mapped to their respective spatial position on the MEA 
array. d. The total average correlation value was calculated for active electrodes during 
spontaneous time of each culture for each day of recording. (n = 3, mean ± std). (*p<0.05; 
ANOVA with post-hoc Tukey) 
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Figure 2-9 a Cross-correlation matrices of mean correlation value (χ) across for the entire time 
of spontaneous activity for each active electrode to every other active electrode. Matrices were 
normalized to singularity for auto-correlation. b Raster plot of average correlation value for each 
electrode during 10 s bins across the entire recording time. 
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Figure 2-10. Burst parameters for all active electrodes at each recording day for the spontaneous 
activity: a spike rate b burst rate c number of spikes in burst d intraburst interval e burst duration 
and f percentage of spikes found in bursts. 
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Figure 2-11. Stimulating training regimens modulates firing patterns in the frequency domain. a. 
Fifteen second representation of spontaneous voltage recording from NS:NS, NS:S, S:NS and 
S:S samples for D 25. b. Smoothened (3 point moving average) and normalized (AUC) power 
spectra was calculated for contiguous 10 s windows across the 4 mins of spontaneous recording 
NS:NS, NS:S, S:NS and S:S. Resulting matrices were averaged across samples. c. Bar graph for 
the sum of power spectral density magnitude from (b) across the spontaneous recording time 
between 0.1 Hz and 1 Hz. (n = 3, mean ± SEM). (*p<0.05; ANOVA with post-hoc Tukey) 
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Figure 2-12 Confocal images of stains for motor neuron expression for non-stimulated (a) and 
stimulated (b) MEB at D9. (Scale bar: 50 µm) 
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 Figure 2-13. Stimulation during neurogenesis alters response to stimulation during network 
formation. Spike counts per each hundredth of a second across the 20 mins of recording was 
graphed for D11 and D25 for samples NS:S (a) and S:S (b). c. Zoom-in of A for 1min, centered 
around the 20 seconds of stimulation at D25 for sample NS:S, the arrows represent the firing rate 
prior to stimulation (FRpre), the firing rate during stimulation (FRstim) and the firing rate after 
stimulation (FRpost). d. Bar graph showing the firing rate increase between Frstim/Frpre for D11-
D25. (n = 9, mean ± SEM). e. Bar graph showing the firing rate increase between Frpost/Frpre for 
D11-D25. (n = 9, mean ± SEM). f. Raster plot of average correlation value for each electrode 
during 10 s bins across the entire recording time. g. Ratio of average correlation value prior to 
stimulation during recording and correlation value post stimulation (χpost/ χpre). (n = 3, mean ± 
SEM) (*p<0.05, **p<0.005; one-tailed T-test) 
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Figure 2-14. RNA Sequencing shows differential expression as a result of optical stimulation 
during neurogenesis. a. Heat map of standard deviation of differential expression for genes with 
p<0.05 (n=749). Genes were primarily clustered for: 1) genes that would overexpress during 
differentiation and underexpressed due to stimulation, 2) genes that would overexpress during 
control differentiation and overexpressed further due to stimulation, 3) genes that would 
underexpress during control differentiation and stimulation minimized that underexpression and 
4) genes that would underexpress during control differentiation and stimulation amplified that
underexpression. (first color column in order: black, red, yellow, blue). Significantly
differentially regulated genes, with p<0.0005 (n=307) were extracted as column plots for: b.
black, c. red, d. yellow and e. blue clusters.
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Figure 2-15 Sum of total power spectra between 0-5 Hz between all four experimental groups for all 
recording done during spontaneous activity. (n = 3, mean ± SEM). 
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Figure 2-16. Bar graphs showing the differentially expressed genes that satisfied the significance 
threshold (p<0.0005) and have been reported to be related to neural development and function 
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Table 2-1. Expression comparisons for phenotypic gene targets 
Gene Description 
log.FC 
D2 v NS 
FDR p 
log.FC 
NS v S 
FDR p 
ESC - Pluripotency 
OCT ¾ - 
(POU5F1) 
-1335.2 1.32E-08 -1.01074 0.993303 
NANOG -195.156 1.54E-08 1.291579 0.610174 
SOX2 
POU domain, class 5, transcription factor 1 
Nanog homeobox transcription factor SRY 
(sex determining region Y)-box 2 -1.1334 0.152156 -1.15112 0.32166 
Neuronal Population 
Neurod6 78.42929 2.04E-09 1.298647 0.378425 
Fox-3 77.39941 3.59E-10 -1.17408 0.501273 
NEF 
neurogenic differentiation 2 
RNA binding protein, fox-1 homolog 
3 Neurofilament 92.5854 5.86E-13 -1.02714 0.762375 
Astrocytes 
Aqp4 N/A N/A N/A N/A 
Gfap 27.17674 1.39E-07 -1.14314 0.766754 
Fgfr-3 
Aquaporin 4 
glial fibrillary acidic protein 
fibroblast growth factor receptor 3 59.96818 2.87E-10 1.029678 0.917007 
Oligodendrocytes 
Mbp 10.7271 8.42E-09 -1.00645 0.984504 
Olig2 0.006191 -1.21048 0.094616 
Mog 
myelin basic protein oligodendrocyte 
transcription factor 2 myelin 
oligodendrocyte glycoprotein 
-1.24175
7.42182 5.11E-07 1.168882 0.60045 
Motor Neurons 
ChAT 46.15114 2.36E-06 1.55963 0.508302 
MNX1 21.12197 5.35E-11 1.15419 0.234447 
PAX6 
choline acetyltransferase 
motor neuron and pancreas homeobox 1 
paired box 6 16.48545 2.91E-09 1.164541 0.454262 
Glutamatergic Neurons 
Slc17a6 solute carrier family 17 (sodium-dependent 
inorganic phosphate cotransporter), member 6 
7.715048 4.04E-08 -1.07919 0.747595 
ADORA2A adenosine A2a receptor 5.181662 2.93E-05 -1.10407 0.828501
Grina
glutamate receptor, ionotropic, N-methyl D-
aspartate-associated protein 1 (glutamate
binding)
3.733777 2.21E-09 1.173808 0.900906
GABAergic Neurons
Slc6a1
solute carrier family 6 (neurotransmitter 
transporter, GABA), member 1
68.94282 6.07E-11 1.07414 0.710842
GAD65 glutamic acid decarboxylase 2 56.14012 3.24E-10 -1.0758 0.764206
GABA
gamma-aminobutyric acid receptor associated
protein
2.496022 1.11E-07 1.239422 0.064079
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Table 2-2. Significantly (p<0.0005) differentially expressed genes reported in literature as regulators 
of neural development 
Gene Description Function References 
Npdc1 neural proliferation, 
differentiation and control 1 
Responsible for regulating differentiation. Upregulated 
in adult brains compared to young brains 
Qu, X. et al. 39, Evrard, C. et 
al.40,  Galiana, E. et al.41,  
Sansal, I. et al.42  
Crabp2 cellular retinoic acid binding 
protein II  
Upregulated in differentiated Motor Neurons, and 
downregulated in mature motor neurons 
Boucherie, C. et al., 
Chaerkady, R. et al., Zhang, 
Q. et al.
Snap47 synaptosomal-associated 
protein, 47  
Involved in unique fusion machinery for postsynaptic 
and presynaptic function 
Münster-Wandowski, A. et 
al. Holt, M. et al. Arora, S. et 
al.  
Tubgcp4 tubulin, gamma complex 
associated protein 4  
Important in the nucleation and polar orientation of 
microtubules 
Scheidecker, S. et al. 
Sánchez-Huertas, C. et al. 
Aplp1 
amyloid beta (A4) precursor-
like protein 1  
Supports maintenance of dendritic spines and basal 
synaptic transmission. High impact on synapse 
formation and synaptic plasticity. Is upregulated during 
synaptogenesis and is essential for proper synapse 
formation. 
Mayer, M. C. et al. 43, 
Schilling, S. et al.44, Weyer, S. 
W. et al. 45, Klevanski, M. et
al.46, Kim, T.-W. et al.47 
Cacng7 calcium channel, voltage-
dependent, gamma subunit 
7  
Critical to Neural communication for Ca-dependent 
fusion of two secretory organelles: synaptic vesicles (SV) 
and neuropeptide-filled dense-core vesicles (DCV). 
Regulates the trafficking and gating properties of AMPA-
selective glutamate receptors (AMPARs). 
Yang, L. et al., Kato, A. S. et 
al.  
Cnih2 
cornichon family AMPA 
receptor auxiliary protein 2  
Influences the efficacy of excitatory synaptic 
transmission. Slows synaptic transmission for reliable 
and successful transmission of a sugnal accros the 
synapse 
Boudkkazi, S. et al., 
Boudkkazi, S. et al., Shi, Y. et 
al. Gu, X. et al.  
Insyn1 
inhibitory synaptic factor 1  
Regulates postsynaptic inhibition and contributes to 
brain development 
Gamlin, C. R. et al., Uezu, A. 
et al.  
Vamp2 
vesicle-associated 
membrane protein 2  
Involved in the dockin and/or fusion of synaptic vesicles 
with the presynaptic membrane. It forms a distinct 
complex with synaptophysin. 
Russell, C. L. et al. Schwarz, 
T. L. Winkle, C. C. & Gupton,
S. L. Winkle, C. C. & Gupton,
S. L. Koo, S. J. et al.
Reep2 receptor accessory protein 2  Expressed in neuronal exocytotic tissue 
Sjöstedt, E. et al. Esteves, T. 
et al. Hübner, C. A. & Kurth, I. 
Hurt, C. M. et al.  
Ngfr 
nerve growth factor receptor 
(TNFR superfamily, member 
16)  
Receptor for member of signaling pathway activating 
neurothrophins, p75NTR 
Huang, E. J. & Reichardt, L. F. 
Barrett, G. L. & Bartlett, P. F.  
Nptx1 
neuronal pentraxin 1  Key factor in synapse loss and neurite damage 
Omeis, I. A. et al., Abad, M. 
A. et al., Dodds, D. C. et al.,
Tuba1a
tubulin, alpha 1A [
Key factor in axon and dendritic growth and network
development
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CHAPTER 3: ENGINEERING GEOMETRICAL 3-DIMENSIONAL 
UNTETHERED IN-VITRO NEURAL TISSUE MIMIC1 
3.1 INTRODUCTION 
The design of living tissue to create specific shapes and forms is arguably one of the main 
obstacles in the forward-design of engineered tissues, cellular systems, and biological machines. 
Given the fact that three-dimensional structures are critical to recapitulate many physiologically 
relevant characteristics, a major goal of tissue engineering is to achieve customizable and viable 
3D cell cultures. To an extent, this has been achieved by engrafting cells of interest on synthetic 
structures (1), or more recently providing cells with protein matrices such as Matrigel and fibrin 
which facilitate cell-cell and cell-extracellular matrix (ECM) interactions (2–5). This approach 
creates a liquid state of protein-rich solutions mixed with cells. After subsequent polymerization, 
3D structures are formed and the cells are allowed to grow and function (Figure 3-1a). 
Such an approach has been used to differentiate progenitor cells towards developing 
functional organoids that mimic physiological morphologies and functions. For example, muscle 
cells have been differentiated into actuating tissue for development of biohybrid actuators for 
soft robotics (6, 7), to develop models for drug discovery or therapeutic studies (2, 8), as well as 
studies on healing in 3D and tissue regeneration (9, 10). An interesting observation has been that 
by providing a mold during the culture, the cell-matrix solution can be compacted into stable 
1 This section is a reproduction of the following first authored journal article: 
Gelson J. Pagan-Diaz, Karla P. Ramos-Cruz, Richard Sam, Mikhail E. Kandel, Onur Aydin, M. Taher A. Saif, 
Gabriel Popescu, Rashid Bashir. Engineering geometrical 3-dimensional untethered in vitro neural tissue mimic. 
Proceedings of the National Academy of Sciences Dec 2019, 116 (51) 25932-25940; DOI: 
10.1073/pnas.1916138116. 
Author Contributions: G.J.P.-D. and R.B. designed research; G.J.P.-D., K.P.R.-C., R.S., M.E.K., O.A., M.T.A.S., 
and G.P. performed research; M.E.K. and G.P. contributed new reagents/analytic tools; G.J.P.-D., M.E.K., and G.P. 
analyzed data; and G.J.P.-D. and R.B. wrote the paper. 
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geometries due to internal stresses generated by traction forces generated by the engrafted cells 
(11). In other words, the shape of the resulting construct can be determined by the 3D printed 
molds, which are fabricated using bio-printing approaches, such as a stereolithography apparatus 
(SLA) 3D printer (Figure 3-1b). Given the needs and interests in 3D neuroengineering, using this 
approach of cell-matrix compaction for the formation of controlled 3D neural architectures could 
be highly beneficial.   
Currently, 3D neural tissue is often obtained from animal models or from spherical embryoid 
bodies spontaneously formed during stem cell differentiation (12–14). These embryoid bodies 
are currently unable to be scaled up due to diffusion limitations, placing limitations on their 
compatibility with specific experimental platforms. For example, fabrication of such untethered 
and mechanically strong neural tissue mimics could help in the assessment of new electrodes for 
neural functionality, neurotransmission and the assess biocompatibility and neural damage 
during implantation (15–17). On the other hand, efforts to develop free-standing 3D tissue 
models in-vitro that incorporate neuronal functionality, such as the formation of neuromuscular 
junctions in 3D muscle tissues, are limited when trying to adhere the neurons on the overall 3D 
constructs (12, 18). Having control of the size and geometry of a neural tissue mimic that can be 
handled and installed after neural development can facilitate the assembly of neuro-driven 
biological machines (19). Furthermore, continued advancements towards engineered in-vitro 
neural tissues of various shapes and sizes to develop better models are important to minimize the 
use of animal models (20)(Figure 3-1c). 
In this work, we utilized fibrin as a scaffold to engraft differentiated ESC-derived neurons 
prior to their maturation in order to achieve untethered and geometrically stable neural tissue 
mimics (NTMs) that could be molded into desired shapes. We demonstrated and characterized 
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three shapes: a rod, a cube, and a toroid (Figure 3-1b, Figure 3-2). By using mouse embryonic 
stem cells, we compared seeding cell densities to determine a protocol for tissue formation of 
various shapes. We also characterized development and functionality, first using mouse-derived 
embryonic stem cells (mESC) due to their shorter differentiation times and reduced costs as 
compared to human stem cells. We then implemented the protocol with human stem cells to 
demonstrate the possibility for clinical and biomedical applications.  
3.2 MATERIALS AND METHODS 
3.2.1 MOUSE EMBRYONIC STEM CELLS (MESC) CULTURE AND DIFFERENTIATION 
Myocin-C inactivated mouse embryonic fibroblast (MEF) were used as a feeder layer for 
mESC expansion. They were seeded at a cell density of ~3.5e4 cells/cm2 and cultured in DMEM 
(Dulbecco’s modified Eagle’s medium) supplemented with 1% fetal bovine serum, 1% L-
glutamine and 1% penicillin-streptavidin in T-25 flasks. After 2 days of recovery, HB9::GFP 
transgenic mouse embryonic stem (mES) cells transfected with (Channelrhodopsin) ChR2-
TdTomato were seeded at 4*104 cells/cm2 in mESC proliferation media consisting of: low 
glucose DMEM with 15% (v/v) FBS, 1% (v/v) each of penincillin-streptomycin, L-glutamine, 
EmbryoMax nucleosides and MEM non-essential amino acids and freshly supplemented with 0.1 
mM β-mercaptoethanol (LifeTechnologies) and 0.1% (v/v) mLIF (MilliporeSigma) before every 
daily media change. 
Differentiation was begun when mESC colonies were >70% confluency. At the appropriate 
time, we added neural differentiation media (nDM) consisting of 44% (v/v) advanced 
DMEM/F12 , 44% (v/v) Neurobasal, 10% (v/v) KnockOut serum replacement 
(LifeTechnologies) and 1% (v/v) penicillin–streptomycin , 1% (v/v) L-glutamine(Cellgro 
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Mediatech, Inc.), and freshly supplemented with 0.1 mM β-mercaptoethanol. Cultures were 
incubated for 1-2 hrs before TrypLE was added to each flask. After detachment, the cells were 
centrifuged, resuspended in nDM and seeded at a density of 2e6 cells/dish in 100 mm low 
adhesion dishes with 10 mL nDM supplemented with Noggin (50ng/mL), bFGF (20ng/mL) and 
FGF-8 (20ng/mL) (Invitrogen). The next day, floating cells were collected to remove adhered 
non-neuronal lineages from the culture. On the following day, neural embryoid bodies (EBs) 
were replated in nDM supplemented with 1µM of retinoic acid (RA) (MilliporeSigma) and 1µM 
smoothened agonist (SAG) (EMD Chemicals). Media was then changed daily, taking care to not 
disrupt the forming EBs. 
3.2.2 HUMAN EMBRYONIC STEM CELL (HESC-H9) CULTURE AND 
DIFFERENTIATION 
Differentiation of human embryonic stem cells (H9) (WiCell, WA09) into neurons was 
achieved by following established protocols. Briefly, H9 were dissociated, using Accutase, and 
seeded on Matrigel (Corning)-coated plates using mTeSR1 (Stem Cells Technology) and 10mM 
ROCK inhibitor (Stem Cells Technology). After 24 hours of seeding we started differentiation 
into Neural Epithelial Progenitors (NEP) by replacing the H9 media with neuronal medium 
which was composed of DMEM/F12 (Stem Cells Technology), Brainphys medium (Stem Cells 
Technology) at 1:1, 1 × N2 (Stem Cells Technology), 2 × NeuroCult™ SM1 Neuronal 
Supplement (Stem Cells Technology), 50 µg/mL ascorbic acid (Stem Cells Technology), and 1 × 
penicillin/streptomycin (Sigma). In order to promote neurogenesis, the neuronal medium was 
supplemented with 3 μM CHIR99021 (CHIR) (Stem Cells Technology), 2 μM DMH1 (Stem 
Cells Technology) and 2 μM SB431542 (SB) (Stem Cells Technology), and changed every other 
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day for 6 days. Then, neuronal medium was supplemented with 1 μM CHIR, 2 μM SB, 2 μM 
DMH1, 0.1 μM Retinoic Acid (RA) (Sigma) and 0.5 μM Purmorphamine (Pur) (Stem Cells 
Technology), and changed every other day for 6 days. Afterwards, neural progenitor cells were 
split 1:6 and plated in PLO (Sigma) /Laminin (Sigma) coated plate. To start differentiation into 
neurons, neuronal medium was supplemented with 0.5 μM RA and 0.1 μM Pur for 6 days. Then, 
for neuronal maturation, after formation of nerve tissue, we also added 0.1 μM Compound E, 
1mM Dibutyryl-cAMP (Stem Cells Technology), 10 mg mL brain-derived neurotrophic factor 
(Stem Cells Technology) and 10 mg mL ciliary neurotrophic factor (Stem Cells Technology).  
3.2.3 NEURAL TISSUE MIMIC FORMATION 
On day 5 of differentiation, mouse-derived motor-neuronal embryoid bodies (MEBs) were 
dissociated in TypLE for 3mins, pipetting every minute. It was observed that dissociation had to 
occur prior to or at the very early stages of maturation of embryoid bodies (EBs), otherwise 
tissues would not compact due to excessive cell death.(8, 21) This is likely because of an 
elevated amount of innervation across the EB, which would be ruptured during 
dissociation(22).At the reported seeding densities, we observed that 0.5mL of TypLE per dish of 
EBs worked optimally, as too harsh trypsinization seemed to impede tissue compaction upon 
engrafting in fibrin hydrogels. Dissociated cells were then counted and aliquoted at the desired 
cell densities. They were then mixed with 30% Matrigel (Corning), 4 mg/mLfibrinogen (Sigma‐
Aldrich), and 2 U per mgFibrinogen of thrombin (Sigma‐Aldrich), for a total of 100 µL of solution 
per batch. Each cell‐fibrin solution was dispensed in 25 µL aliquots to a PEGDA mold. (23–25) 
The fibrin hydrogel was permitted to cross-link for 2hrs before adding nDM supplemented with 
supplemented with 10 ng/mL each of GDNF and CNTF (Neuromics). Media was changed daily, 
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and tissues were permitted to compact for 4 days before releasing from molds. Human-derived 
tissues were formed analogously to mouse-derived tissues, doing the dissociation step at day 18 
of differentiation. 
3.2.4 DESIGN AND 3D PRINTING OF MOLD 
Tissue molds were 3D printed using a SLA Asiga Pico 2 (Asiga). We used 18% (v/v) 
PEGDA MW 700g/mol (SA) with 0.1% w/v LAP (Asiga) as a photoinitiator and 0.15% (v/v) 
Sudan I dye (Asiga) to minimize photo-scattering effects which affected geometric resolution. 
Washes with DI water between key layers was done to achieve concave structures. To remove 
dye prior to culturing, fabricated parts were bleached with 10% bleach for 2hrs, followed by 1hr 
wash in 70% EtOH and then washed with phosphate-buffered saline (PBS). If needed, molds 
were further sterilized with 30min exposure of UV light. Because of the low stiffness of the cell-
hydrogel matrix, fabricating bridges was deemed necessary for the initial stage of compaction to 
ensure the tissue would stay inside, and later broken off in order to get access to the tissue. 
3.2.5 MEA ELECTROPHYSIOLOGY 
Microelectrode array chips were prepared for seeding by an initial precoating of poly-D-
lysine (MilliporeSigma, MO) at 100 µg/mL in DI Water overnight. The chips were then washed 
and allowed to dry. Laminin (50 µg/mL) slowly thawed at 4oC was added and the chip incubated 
for 20 minutes at 37oC. Extra laminin was aspirated, and tissues were seeded before the chip 
dried. Tissues were then permitted to adhere for 1.5 hours before adding fully supplemented 
media. Recordings were performed on seeded 60-electrode chip using a MEA 2100-Lite 
Amplifier (Multi Channel Systems MCS GmbH, Germany) maintained at 37oC using a TC02 
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temperature controller (Multichannel Systems). Recording was done at a gain of 1100 and a 
bandwidth of 1 to 10kHz. Data was acquired at a sampling frequency of 10kHz as well using a 
rack set in MultiChannel Experimenter. Recordings were analyzed post hoc after baseline 
fluctuations were removed with a high-pass filter (2nd order Butterworth filter) with a highpass 
cut-off frequency of 200Hz, using MultiChannel Analyzer (Multichannel Systems). Temporal 
analysis of spike and burst events (instruments: Spike Analyzer and Burst Analyzer) was 
performed with the same software after a threshold of 5 standard-deviations of the mean noise 
was used to detect action potential events. Discreet sequences of timestamps of action potential 
events per electrode were used to calculate the cross-correlation at zero lag and normalized to 
unity for autocorrelation using MATLAB. This value was used to quantify synchronicity. Raw 
spike trains were extracted through MultiChannel Manager (MultiChannel Systems) for 
visualization. 
3.2.6 OPTOGENETIC STIMULATION AND PHARMACOLOGIC TESTING 
Optogenetic stimulation for the mouse-derived tissue was performed on 2 tissues of each 
shape (n=2*3 shapes). We used a Laser Diode with an integrated Driver set at 450nm (Doric 
Lenses, Quebec, Canada) attached to a 50 µm core multimode NA 0.22 Fiberoptic Patchcord and 
a collimator with 6mm focal length fitted to the optical fiber with FC receptacle and fitted into 
12.7 mm cylinder, 20 mm long to generate a 2.5mm diameter beam. Stimulation patterns were 
designed with Doric Neuroscience Studio. During recording, stimulation was done in 5ms pulses 
at 20Hz radiated in 2 s cycle periods at 50% duty cycle for 20 sec every minute during the 5 mins 
recording sessions, for a total of 4 stimulations (n=4). 
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Pharmacologic substances were used for the human-derived tissue after 21 days of culturing 
in MEAs (n=6). The medium for each MEA sample was replaced with 2 mL of fresh medium 
mixed with the selected substance. After 1 min of incubation, recordings were performed for 5 
minutes and the sample was washed 3 times with fresh warm media every 30 sec and later 
incubated for 5 minutes, before adding the subsequent substance. The post-synaptic response was 
pharmacologically modified with 6 cultures in the following order: spontaneous activity was first 
measured in fresh media, before adding DL-2-amino-5-phosphonopentanoic acid; D-AP5, 20 μM 
(MilliporeSigma, MO) (an NMDA antagonist) followed by a washout and an additional 
measurement in fresh media. Later, gamma-aminobutyric acid; GABA, 100 μm 
(MilliporeSigma, MO) was added, and followed by 1(S),9(R)-(-)-bicuculline methiodide; 
bicuculline, 10 μM (MilliporeSigma, MO) (a GABAA
 antagonist). 
3.2.7 CRYOSECTIONING AND PARAFFIN-EMBEDDED SECTIONING 
For confocal imaging, tissues were fixed for 20 min in 4% paraformaldehyde. After washing 
with PBS, buffer was sequentially substituted with sucrose solutions (10% w/v, 20% w/v and 
30% w/v). After an overnight wash at 30% w/v sucrose solution in 4oC, tissues were embedded 
in OCT solution (Tissue-Tek, CA) and frozen on dry ice prior to storing in -20oC. Molds were 
sectioned in 20µm thick layers unto SuperFrost Plus slides (ThermoFisher Scientific, MA) and 
air dried at room temperature for 1hr. Phosphate buffered saline (PBS) was used to wash the 
OCT and slides were dried at 37oC for ~1 hr to improve adhesion while avoiding to overdry. 
Samples were then bordered with water repellent barrier using a PAP Pen (Abcam) and then 
blocked using antibody diluent (AD) (LifeTechnologies) in 4oC at least 12hr.  
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For H&E staining, tissues were fixed in 10% formalin for 1 day, washed 3 times with 70% 
ethanol and stored at 4oC until ready for the manual processing, as these tissues were still too 
delicate for standard automated paraffin processing. Samples were embedded in paraffin 
following Schedule II of Table I of Jali et al, JOMPF, 2015.(26) Embedded samples were 
sectioned in 5µm thick slices using a microtome mounted on glass slides and dried overnight.
3.2.8 IMMUNOSTAINING AND HISTOLOGY 
Immunocytochemistry was performed on sample cryoslices after blocking. All staining was 
done the same for the different resulting cocktails: primary antibodies were diluted in AD, added 
to samples and incubated for 24hr at 4oC in a water vapor saturated enclosure. Afterwards, 
samples were washed in PBS for 5 min at room temperature three times and the cocktail with 
the corresponding cocktails of secondary antibodies were added and incubated for 2hr at room 
temperature. The used staining cocktails are summarized in the following table: 
Table 3-1 Antibodies used for immunostaining
Cocktail 1ryAB Company Cat# Host Dilution Factor 2ndAB 
1 CNPase Millipore MAB326 M 1:1000 AF647 
2 GFAP Millipore MAB360 M 1:1000 AF647 
3 
GAD65/67 Santa Cruz 
Biotechnology 
SC7513 G 1:100 AF488 
VGlut Synaptic 
Systems 
135 304 GP 1:500 AF647 
4 
ChAT Abcam Ab18736 S 1:1000 AF488 
NeuN Millipore MAB377 M 1:500 AF647 
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5 
Tenascin-C Abcam Ab108930 R 1:500 AF647 
NeuN Millipore MAB377 M 1:500 AF488 
6 
Laminin Abcam Ab11575 R 1:500 AF647 
NeuN Millipore MAB377 M 1:500 AF488 
7 
Collagen IV Abcam Ab6586 R 1:500 AF647 
NeuN Millipore MAB377 M 1:500 AF488 
8 
Fibronectin Abcam Ab2413 R 1:500 AF647 
NeuN Millipore MAB377 M 1:500 AF488 
9 
Fibrinogen Abcam Ab34269 R 1:500 AF647 
NeuN Millipore MAB377 M 1:500 AF488 
Nuclei were stained with DAPI (1:5000) during the two hours of secondary staining. After 
washing overnight at 4oC in PBS, samples were mounted with Prolong Diamond antifade 
(ThermoFisher, MA) under a sealed coverslip and imaged using Zeiss 710 Confocal microscope 
(Carl Zeiss Microscopy).  
Mounted paraffin samples were stained with hematoxylin and eosin (H&E). After 24 h, they 
were imaged with Nanozoomer, a digital pathology system. For quantification of cell 
distribution, images were processed with ImageJ. A threshold was applied to each image to 
detect nuclei and the ImageJ Particle Analyzer feature was used to determine X–Y coordinates of 
each nucleus on every image. Simple MATLAB code was used to map the location of each 
nuclei in the image as well as calculating the minimum distance of each nucleus to the perimeter. 
Table 3-1 (Cont.) Antibodies used for immunostaining
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3.2.9 QUANTITATIVE PHASE IMAGING 
To investigate the change in cellular dry mass we turn to quantitative phase imaging 
(QPI)(27), a label-free imaging modality that provides interferometric contrast via tissue 
refractive index. Gradient Light Interference Microscopy (GLIM) is a QPI technique, which has 
recently extended this capability to strongly scattering specimens(28, 29) (also, Kandel et al, Nat. 
Comm., in press). To image the large volumes in this work, we acquire time lapse quantitative 
phase gradient tomograms consisting of a 3 x 3 x 3 mm3 volume by performing a z-scan at each 
tile in a 2 x 2 mosaic. The data is then integrated to obtain the quantitative phase map, yielding 
the distribution of cellular dry mass density. We then take the change in percentage total dry 
mass for each of the four mosaic volumes, to estimate the change in total dry mass. Interestingly, 
we observe statistically insignificant differences between categories hinting that the mechanism 
for different behavior changes is a reorganization of the tissue rather than a change in growth 
behavior. 
3.2.10 RNA EXTRACTION AND REAL-TIME QPCR 
Samples of MEBs were carefully collected and centrifuged at 14000 rpm for 15 mins, while 
single tissue samples were divided in individual Eppendorf tubes. After aspirating supernatant, 
samples were flash frozen using liquid nitrogen and immediately stored at -80°C, until mRNA 
extraction. Total RNA was collected and purified using the RNeasy Mini Kit Part 1 (Qiagen). 
The total RNA concentration was quantified using a Nanodrop spectrophotometer. Only samples 
with absorption ratios (A260/280) >2.0 were included in this study. Synthesis of cDNA was done 
with 100ng RNA per sample with SuperScript IV VILO EzDNase Kit (ThermoFisher Scientific). 
Triplicate assays were performed by QuantStudio 3 (ThermoFisher Scientific) in TaqMan 
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Universal Master Mix II (Applied Biosystem). The probes used for monitoring development of 
neuronal populations for this study were: Adenosine A2a (Excitatory neurons)[Assay ID: 
Mm00802075_m1], Tyrosine Hydroxylase (Dopaminergic Neurons) )[Assay ID: 
Mm00447557_m1], Choline Acetyltransferase (Functional Motor Neurons) )[Assay ID: 
Mm01221880_m1], Hb9 (Motor Neuron Transcription Factor) )[Assay ID: Mm01222622_m1], 
NMDAR1 (Glutamanergic Neurons) )[Assay ID: Mm00433790_m1], Paravalbumin 
(Interneurons) )[Assay ID: Mm00443100_m1], GAD67 (GABAergic Neurons) )[Assay ID: 
Mm04207432_g1], GFAP (Astrocytes) )[Assay ID: Mm01253033_m1], CNPase (Myelinating 
Oligodendrocytes) )[Assay ID: Mm01306641_m1]. Probes used to monitor expression levels of 
extra-cellular matrix were Collagen IV [Assay ID: Mm01210125_m1], Laminin )[Assay ID: 
Mm01222029_m1], Tenascin C )[Assay ID: Mm00495662_m1], Fibronectin )[Assay ID: 
Mm01256744_m1], and Fibrinogen )[Assay ID: Mm00513575_m1]. Glyceraldehyde3-
phosphate dehydrogenase (GAPDH, assay ID: Mm99999915) was used as the endogenous 
reference gene. RT-PCR was run at 50 °C for 2min, 95 °C for 2min, and 40 cycles [Denaturing: 
95 °C for 1 s, Extend/Annealing: 60 °C for 20 sec] with ROX, FAM and MGB as reference dye, 
reporter and quencher, respectively.  
3.2.11 DATA ANALYSIS AND STATISTICS 
All data was represented with box plots or bar graphs. Boxes showed the 25-75 percentile, 
whiskers represented ±1 standard deviation (SD), while bar graphs represented mean ± SD. 
OriginLab Software was used to perform all statistical calculation and plotting. Statistical 
difference was analyzed using Unpaired T-test for comparisons between tissue and MEB data, 
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while ANOVA with Tukey’s Post-Hoc was used for the rest. The statistical significance level 
was set for p-values of <0.05.  
3.2.12 ABSOLUTE AND RELATIVE QUANTIFICATION OF REAL-TIME PCR DATA 
Serial dilutions for all 14 targets and our reference target GAPDH were done with triplicates 
of calibrator samples (MEBs at D0). Analysis of qPCR data was done following established 
protocols by Applied Biosystems by ThermoFisher Scientific. Standard curves were formed, and 
linear fits were used to determine the slope for each curve. Slope values were used to calculate 
the Efficiency (E) and Amplification Factor (AF) using the following equations: 
𝐸 =  10(−1 𝑠𝑙𝑜𝑝𝑒)−1⁄ ∗ 100%
𝐴𝐹 =  10
1
−𝑠𝑙𝑜𝑝𝑒⁄  
Experimental CT values were adjusted to account for efficiency variability using the 
equation: 
𝐶𝑇𝑎𝑑𝑗 = log2 𝐴𝐹
𝐶𝑇𝑒𝑥𝑝
Comparative CT Method (ΔΔCT) was used to compare expression levels between the 
developing tissues and MEBs at days D4 and D7 with respect to MEBs at D0. The ΔCT and 
ΔΔCT values were calculated by: 
∆𝐶𝑇 = 𝐶𝑇(𝑡𝑎𝑟𝑔𝑒𝑡) − 𝐶𝑇(reference)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅
∆∆𝐶𝑇 = ∆𝐶𝑇(𝑠𝑎𝑚𝑝𝑙𝑒) − ∆𝐶𝑇(𝑐𝑎𝑙𝑙𝑖𝑏𝑟𝑎𝑡𝑜𝑟)
Finally, values were reported as 𝑙𝑜𝑔(2−∆∆𝐶𝑇), to account for biases caused by exponential
functions. 
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To compare across population targets within same samples, adjusted CT values were 
converted into “quantity” values by calculating 2
−𝐶𝑇𝑎𝑑𝑗 . The “quantity” ratio
(𝑄𝑡𝑎𝑟𝑔𝑒𝑡 𝑄𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅⁄ ) were calculated for each replicate value.
3.3 RESULTS 
3.3.1 SEEDING CELL DENSITY AFFECTS THE STRUCTURE OF THE NEURAL TISSUE 
MIMIC  
Previous works have studied the effects of changing the stiffness of the fibrin matrix on the 
resulting viability of tethered NTMs by changing the concentration of fibrinogen with respect to 
the added thrombin (30–32). We build upon those studies but due to our desire to obtain 
mechanically stable and untethered functional 3D in-vitro constructs, we studied the effect of 
varying the seeding cell concentration. For the purpose of our study, the day in which seeding 
took place was labeled as D0 (Figure 3-3). Prior work on developing untethered muscle tissue 
has reported 5e6 myoblasts/mL as the optimal cell seeding concentration (7, 25). Due to the 
lower traction force per neurons as compared to myoblasts (32), we considered higher seeding 
cell concentrations.(33) The goal was to find a cell concentration that would result in a 
mechanically strong structure while being low enough to lower costs and have high sample 
throughput. For this purpose, we studied 5e6 cells/mL (1X), 12.5e6 cells/mL (2.5X), 25e6 
cells/mL (5X) and 50e6 cells/mL (10X) and observed them for the first 4 days of compaction. 
(Figure 3-4) It was noticed that by D1 for all four concentrations, neurites were extending across 
the fibrin hydrogel. However, for higher concentrations (5X and 10X) dark clusters started to 
form by D4 (Figure 3-5a). This spontaneous re-aggregation towards neural clumps  could lead to 
heterogeneity  across the tissue mimic, and if the clusters become too large could also lead to 
necrosis due to diffusion limitation (34). To investigate the difference in NTM architecture, we 
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measured high-resolution confocal z-stacks of the resulting constructs at the four seeding 
densities stained for beta-tubulin III, a general neural microtubule marker (Figure 3-5b). These 
images showed that higher seeding cell densities caused the cells to re-cluster as EBs and extend 
processes in clumps rather than homogenous neurite extensions, as also seen clearly in the 
frequency domain (Figure 3-5c). Due to the desire to achieve an homogenous internal 
environment to avoid the risks of clustering and optimize the consistency across the construct, 
we further quantified these trends in heterogeneity. For this purpose, the randomness of the 
images were measured using the MATLAB function for entropy, e, defined as, 𝑒 =
− ∑ 𝑝(𝑧𝑖) ∗ 𝑙𝑜𝑔2𝑝(𝑧𝑖) where p contains the normalized histogram counts of the field of view, zi
(35) (Figure 3-5c). We observed that the randomness of the neurite structures was higher for
lower concentrations and decreased significantly for 10X cell concentration. To further 
understand these observations, we performed continuous live quantitative phase imaging using 
Gradient Light Interference Microscopy (GLIM) which allows for a label free method to 
estimate the dry cell mass, i.e. the protein content of the cells (28). The rates were statistically 
insignificant across the groups (Figure 3-5d), hinting that the possible mechanisms for the 
difference are due to the reorganization of the NTM rather than the cellular growth itself.  
3.3.2 SEEDING CELL DENSITY AFFECTS THE COMPACTION AND NEURITE 
EXTENSION OF THE NEURAL TISSUE MIMIC  
We first utilized the rod shape NTM and observed the effects of cell density on the 
compaction of the construct when seeded in the PEGDA molds, and later, the neurite extension 
from the compacted NTM when cultured after compaction. Upon seeding, we measured the 
dimensions of the compacted NTM for the four concentrations being tested with respect to the 
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size of the mold, to which the cell-hydrogel solution mimic initially conformed during the stage 
prior to cross-linking (Figure 3-6a, Figure 3-7). We observed that for the lower 1X 
concentration, the percent decrease as compared to the original dimension was below 10% by D4 
for both the width and the length of the rod (Figure 3-6b). This translated in difficulty of 
handling the 1X NTMs as they would rupture very easily. When the cell concentrations were 
increased to 2.5X and 5X concentrations, the width decreased approximately by 30% and 40% 
respectively, and the length decreased by approximately 50% for both. Interestingly, the highest 
seeding density showed the least compaction, which could possibly indicate reaching a saturation 
of cells within the mold volume. NTMs from each group were placed at D4 on functionalized 
substrates in order to observe the neurite extension, as it was important to ensure that these 
neural constructs were able to innervate and communicate with downstream biological 
structures. For this reason, we measured length and number of neurites extending across the 
periphery of the neural construct. (Figure 3-6c) After two days of the NTM being adhered, we 
observed numerous processes extending from the NTM beyond an initial sheet of membrane 
layer directly connected to the NTM. We observed that for lower seeding concentrations, the 
neurite length reached around 2mm, and significantly decreased for constructs of larger cell 
concentrations (Figure 3-6d).  
Next, the number for neurites extending from the NTM were measured by plotting the cross-
sectional profile and counting the peaks (Figure 3-6e). The neurite numbers significantly 
increased between 1X and 2.5X, and then stayed constant for the subsequent concentrations. The 
fact that the three highest concentrations seemed to have similar neurite counts, while having 
such differences in neurite length, could be related to the observed internal clustering of cells 
(Figure 3-5c). While observing the neurite extension over a longer period of time, beyond the 2nd 
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day of adhesion (D6+), would have been even more useful, we did observe neurons migrating 
from the NTM and into the substrate, extending their own processes, and making it hard to 
distinguish from processes directly extending from the NTM. Nevertheless, these observations 
led us to select 12.5e6 cells/mL (2.5X) as an appropriate concentration for the rest of the study. 
3.3.3 NEURAL TISSUE MIMICS CAN BE MOLDED INTO VARIOUS SHAPES 
Upon establishing a reproducible cell culture protocol, we then fabricated molds of different 
shapes to confirm that mechanical stability observed in the rods would be preserved in other 
shapes. First, a cube was designed by adjusting the dimensions of the mold to keep the seeding 
volume constant as the rod design earlier (Figure 3-8a). A similar compaction trend was 
observed for these cubes, where original volume decreased by approximately 60-70% (Figure 3-
8b). To show a possible applicability of cube shaped NTMs for developing 3D neural circuits, 
we fabricated a holding mold with slits between the enclosures in which to place the compacted 
cubes. The goal was to add ECM around the cubes and observe if the cubes would extend 
processes across it (Figure 3-8c). After 4 days of “installation”, the cubes were observed to 
localize towards the center, which would be explained by remodeling of the ECM as neurites 
extend across and pull on each other. We confirmed by confocal imaging the presence of dense 
extension of processes between the slits. 
In parallel, a mold for a toroid was fabricated in order to obtain a neural ring (Figure 3-8d). 
The compaction process here was different, as a solid structure held the inner diameter constant, 
while the outer diameter decreased due to the cell-driven hydrogel compaction, resulting in the 
thickness decrease by approximately 60% (Figure 3-8e). This shape was especially significant as 
it proved that the formation of NTMs by these protocols resulted in stable geometries, even if the 
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NTM was cut in half (Figure 3-9). Furthermore, because the compaction occurred while an 
external structure kept the cell-matrix liquid, we hypothesized that the structures could be 
removed and installed onto a cylindrical structure, and (because of the built-in tension), would fit 
‘tightly’. Using Lightsheet microscopy, we observed that installed rings not only fitted tightly 
around the cylindrical substrate but also extended a dense mesh of processes (Figure 3-8f).  
3.3.4 MATURATION WITHIN THE EXOGENOUS ECM SUPPORTS DEVELOPMENT OF 
NEURAL POPULATIONS 
When presenting this tissue model as a substitute for intact EBs for neural studies, we wanted 
to determine the effect of disrupting EB cells and then reconstructing them in an exogenous 
matrix. For this purpose, we focused on common neural populations such as excitatory and 
inhibitory phenotypes, as well as motor neurons and supporting populations such as astrocytes 
and oligodendrocytes. Initially, we performed confocal imaging of NTM slices and observed that 
between D4 and D7, neural populations seemed to be developing as expected (36–38) (Figure 3-
10a). The staining for vesicles of the excitatory neurotransmitter, glutamate, showed a wider 
propagation of these markers across the slice, while markers that stained for the enzymes 
responsible for synthesis of GABA, a primary inhibitory neurotransmitter, did not show any 
significant signal. Motor neurons were monitored through the ChAT stain and showed an 
increase in ChAT+ neurons across the slice between D4 and D7, observation which was similar 
for the astrocytes and oligodendrocytes stained for GFAP and CNPase, respectively. These 
observations were confirmed and quantified by qPCR and normalized for comparison across 
targets with respect to the housekeeping gene GAPDH using standard curves (Figure 3-11).  We 
compared three known targets for excitatory populations: ADORA2a (AD), Grin1 (GR) and TH; 
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two targets for inhibitory populations: PVALB (PA) and GAD1 (GA); two targets for motor 
neurons: MNX1 (MN) and ChAT (CH); and two targets for supporting cells: GFAP (GF) and 
CNPase (CN) (Figure 3-10b). At D0, as expected, MN is expressed various fold higher than most 
other markers as it is the transcription factor for the differentiation of motor neurons. By D4, MN 
still expressed highly (with respect to other markers) while CH also expressed highly, indicating 
maturation of the motor neurons, as CH is critical in the synthesis of the motor neuronal 
neurotransmitter, acetylcholine. Furthermore, GR, a gene that encodes for the receptor for 
excitatory neurotransmitter glutamate, became highly expressed while the high expression from 
D0 of TH, which encodes for dopamine synthesizing enzymes in dopaminergic neurons, showed 
to be only transient. Prior studies have shown this to be a common occurrence in many 
developing neurons from the central nervous system (39, 40). More importantly, expression of 
astrocytes and myelinated oligodendrocytes also increased, almost as much as that of functional 
motor neurons. On D7, the same trends from D4 were observed, however the expression of the 
supporting cells surpassed the expression of other markers. Since both astrocytes and 
oligodendrocytes are mitotic while neurons are generally considered to be amitotic, it would be 
worth considering how would a large neuron to glial ratio affect 3D culture viability and how 
this would affect the lifetime of these NTMs. Nevertheless, we also observed the same 
expression of markers during development in intact EBs that were grown in parallel. (Figure 3-
12). We then compared these observations between NTM and EBs for the targets that reported 
cycle threshold (Ct) values above 35 by D7 (Figure 3-13). When both NTM and EBs were 
compared at D4 and D7 with respect to pre-dissociation EBs at D0, no significant differences 
were found for almost any of the markers at both days of study (Figure 3-10c). This served as an 
indication that the initial disruption and reconstruction of a foreign ECM did not affect the 
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differentiation and development of general neuronal populations. While this initially was 
surprising, given the constructs’ millimeter-scale sizes which greatly surpassed the EB size and 
were past the diffusion limit for most tissues, upon imaging the tissues through a scanning 
electron micrograph (SEM), we observed that the ECM on the outside had pores that were much 
larger than macromolecules in the media. This would indicate that nutrients were able to diffuse 
in and out of the tissue (Figure 3-14). 
Finally, H&E stains were performed in histology slices to determine the distribution of cells 
within the NTM (Figure 3-10d). After processing the images, they were segmented in 
200µm*200µm sized bins and cells were counted within each bin to have a spatial notion of 
local cell concentrations (Figure 3-10e). Upon observation, it was apparent that cells, while still 
alive and distributed across the NTM (which was clear by close inspection of the histology 
slices), would concentrate closer to the edges and 75% of all cells seemed to be distributed 
within the first 150µm from the edge. Furthermore, quantifying the expression of the principal 
ECM proteins in primary neural tissue and comparing between the intact EBs and the in-vitro 
NTM showed again no significant disruption of expression during development (41–44) (Figure 
3-15). These observations would suggest that the fabrication of in-vitro NTM as demonstrated by
this work could serve as a model to study various developmental phenomena despite the 
disruption of EB development during the formation of the 3D neural constructs. 
3.3.5 IN-VITRO NEURAL TISSUE MIMIC DEVELOPS SPONTANEOUS ELECTRICAL 
ACTIVITY AND SHOWS SPATIAL CONNECTIVITY 
While we are able to control the form and shape of the NTM, the electrical functionality must 
also be validated. Multiple studies of embryoid bodies differentiated to various neuronal 
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phenotypes have shown the development of spontaneous electrical activity (45–47). To assess 
the electrical activity, the NTMs were placed on functionalized Micro Electrode Arrays (MEAs). 
The electrodes that recorded the most activity were directly under the NTM compared to 
electrodes away from the construct (Figure 3-16a). This activity was quantified primarily by the 
spike rate and was shown to gradually increase with time, as expected for maturing neural 
networks (Figure 3-16b, Figure 3-17). Synchronized bursting can be appreciated by the spike 
raster plots, which showed some random firing from various outside electrodes from migrating 
neurons but showed structured firing for the electrodes that were under the NTM (Figure 3-16c). 
Furthermore, quantifying synchronicity of the firing by calculating the average cross-correlation 
values per electrode with respect to the rest of the electrodes showed synchronous behavior 
across the length of the construct (Figure 3-16d, Figure 3-18). 
Given the conventional perspective that ‘neurons that fire together, wire together’, we 
inferred that the synchronous bursting observed in the spontaneous activity should indicate a 
strong connectivity across the tissue. To prove this, we formed NTMs from optogenetic mESC, 
placed the construct on the MEA after compaction, and used a focused light with a small spot 
size (~2.5 mm) to stimulate the section of the NTM that was not on the MEA sensing area. This 
experiment was performed for the rod and the toroid, as the cube dimensions did not allow for 
the stimulation to be done only on sections that were removed from the recording electrodes 
(Figure 3-16e). The average firing rates of the 20 s intervals corresponding to before, during, and 
after stimulation were mapped to their respective electrodes (Figure 3-16f, Figure 3-19). During 
stimulation away from the measuring electrodes, an increase in firing rate clearly indicates that 
the processes are electrical connected across the entire NTM. As expected, there would be some 
variation in the response as the interface between the construct and the measuring electrodes 
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might not be identical and hence result in a difference in the magnitude of the measured signal. 
This stimulation was repeated 4 times for two samples of each shape, and the average firing rate 
for all the electrodes showed a consistent increase in activity from electrodes away from the 
stimulation (Figure 3-16g). By using a small spot size and stimulating the rod and the toroid on a 
section of the neural construct away from the electrodes and still detect the evoked response at 
the electrodes proved that these NTMs were not only spontaneously active but also forming 
connected networks that extended across the NTM geometry. 
3.3.6 NEURAL TISSUE MIMIC FORMATION WITH HUMAN ESC 
While utilization of mouse derived embryonic stem cells can still provide an experimental 
platform for many studies within tissue engineering research, the demonstration of new 
biofabrication methods in human derived stem cells is highly attractive for the development of 
translational research models. Using the protocol described earlier in this paper, hESC-derived 
neural cubes were fabricated (48–50) (Figure 3-20a). For these NTMs, the same cell seeding 
concentration used for the mouse NTM were mixed with the protein solution used previously and 
poured into the mold. These NTMs proceeded to compact, showing similar percent volume 
decrease as the mouse derived NTMs (Figure 3-20b). Furthermore, histology sections showed 
again similar cell distribution patterns as seen for the mouse-derived NTMs and effective 
differentiation of excitatory neuronal populations as shown by positive staining of vGlut (51) 
(Figure 3-20c, Figure 3-21). Moreover, we placed and seeded hESC-derived NTMs on MEAs to 
validate spontaneous activity from the neural constructs (Figure 3-20d, Figure 3-22). These 
human-derived constructs showed spontaneous bursting along the action potential firing (Figure 
3-20e). More importantly, we measured the response to known neural antagonists from the
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seeded NTMs. Following MEA studies with hESC-derived neuronal cultures, spontaneous 
activity was measured followed by the addition of D-AP5 (30µM), an NMDA receptor 
antagonist, followed by a washout to determine if the samples would return to baseline firing 
(47).  Afterwards, the inhibitory neurotransmitter GABA was added (100µM), followed by the 
GABA receptor antagonist bicuculine (30µM). The firing rate responded as expected: addition of 
D-AP5 decreased the firing rate with respect to the spontaneous activity and returned back when
washed away (Figure 3-20f). When GABA was added, a more acute inhibitory response was 
observed, only to reverse upon the addition of bicuculine. Furthermore, effects to these drugs 
were also observed in the bursting (Figure 3-20g). Several electrodes had been recording 
spontaneous bursting, and dissipated when adding the NMDA receptor antagonist, D-AP5, and 
the inhibitory neurotransmitter GABA. Both washing away the D-AP5 and blocking GABA 
receptors with bicuculine, resulted in the return of this bursting phenomena, with the latter 
increasing the number of bursts being recorded. However, while bicuculine did cause more than 
a two-fold increase of the number of bursts recorded, observing the structure of the burst 
themselves, there seemed to be no significant difference between the burst duration (Figure 3-
20h) or the spike frequency within the burst (Figure 3-20i). These observations led us to 
conclude that these NTMs could be utilized in translational studies while also taking advantage 
of the capability of molding the neural constructs in the desired shapes for optimized bottom-up 
experimental design. 
3.4 DISCUSSION 
This work demonstrated the fabrication of untethered functional NTMs that can be molded into a 
variety of 3-dimensional shapes and sizes. Mouse embryonic stem cell-derived neurons, when 
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mixed with fibrin and ECM and allowed to differentiate in a 3D printed mold, resulted in a 
compaction of the cells and matrix. This ultimately resulted in a NTM that did not perturb the 
development of the neural populations when compared with the standard environment of the 
embryoid body while overcoming geometrical limitations of the spherical EB which at many 
times restricts experimental design and applications. By providing this reproducible protocol to 
obtain dense and modular neuronal tissue models, development of novel platforms to assess 
neural function in 3D can be advanced, since electrophysiological activity and connectivity that 
extended across the NTM were demonstrated. Finally, we validated our protocol with human 
stem cell-derived neurons to achieve these functional NTMs. These findings could be enhanced 
by expanding control of the biofabrication protocol to include higher precision of neuronal 
population ratios as well as patterning these populations in three dimensions in order to achieve 
phenotype-specific spatial arrangements and functionality as found in in-vivo tissues. The ability 
to recapitulate neural morphology, both internally and externally, could improve translational 
applicability as well as present a better model for the study of emergence of neurological 
phenomena. Overall, these NTMs can have profound applications in drug discovery and 




Figure 3-1. Development of 3D neural tissue mimic (NTM) for biomedical engineering 
applications. (a) Representative schematic of the NTM formation, consisting of differentiation, 
dissociation and engrafting of differentiated neurons in fibrin hydrogel prior to maturation. (b) 
Diagram of SLA 3D Printer used for the fabrication of the three molds used to form different 
neural constructs: rod, cube and toroid. (c) Representation of possible biomedical applications 






















Figure 3-3. Diagrams for culture and differentiation of (a) mESCs and (b) hESCs. 
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Figure 3-4. Representative images of the development of engrafted neu-rons within the tissue, at 
D1, D2, D3 and D4, for the 4 seeding cell concentrations studied. (Scale bar: 50 µm) 
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Figure 3-5. Cell seeding density affects homogeneity internal neuronal architecture of NTM. (a) 
Phase contrast image of the neurons engrafted in fibrin hydrogel at D4 of compaction after 
neural construct formation for the different seeding cell densities from D0: 5e6 cells/mL, 12.5e6 
cells/mL, 25e6 cells/mL and 50e6 cells/mL (scale bar: 50 µm). (b) 3D rendering of confocal z-
stacks across 15 µm of neurites (β-TubIII: green) and nuclei (DAPI: blue), with the 
corresponding representation in the frequency domain obtained through fast Fourier transform 
for the four cell seeding densities (Scale bar: 20 µm). (c) Entropy of neurite alignment for four 
seeding densities at D4 (n=12, *p<0.05 ANOVA with Tukey Post Hoc). (d) Cell dry mass 
change for the four seeding densities between D0 and D4 (n=4).  
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Figure 3-6. Cell seeding density affects compaction and neurite extension from the neural tissue 
mimic. (a) Representative fluorescent image of a compacting NTM (rod) in the mold at D4 
(Scale bar: 1mm). (b) Percent change of the width (WidthD4/WidthD0 *100) and length 
(LengthD4/LengthD0 *100) of NTMs (rods) resulting from the four cell seeding densities (n=5; 
*p<0.05 ANOVA with Tukey Post Hoc). (c) Representative confocal image of tissue seeded on
functionalized substrate showing neurite extension from the NTM (β-TubIII: green and F-actin:
red; Scale bar: 500 µm). (d) Zoom of neurites from (c) across the perimeter of the NTM.
Fluorescent intensity profile was used to detect and count neurites (Scale bar: 50 µm). (e) Length
of neurites extending from the membrane extension from the NTM for the four cell seeding
densities (n=5; *p<0.05 ANOVA with Tukey Post Hoc). (f) Number of neurites per millimeter of
NTM perimeter for the different cell seeding densities (n=5; *p<0.05 ANOVA with Tukey Post
Hoc).
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Figure 3-7. Compaction of Rod Tissue. (a) Representative image at D4 of rod tissues seeded at 
different cell densities. The dashed line shows the mold boundary and the tissue’s size at D0 
(1X: 5e6 cells/mL; 2.5X: 12.5e6 cells/mL; 5X: 25e6 cells/mL; 10X: 50e6 cells/mL). (b) 
Representative images of compaction of the rod tissue, seeded at the 2.5X concentration, for D1, 
D2, D3 and D4. (Scale bar: 1mm) 
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Figure 3-8. Formation of neural tissue mimics of different shapes. (a) Compaction of cube 
shaped construct during the first 4 days, and percent change of side length [(Average Length at 
D4)/(Average Length at D0)*100] (Scale bar: 1mm). (b) Confocal of compacted cube NTM 
(Scale bar: 500 µm). (c) Installation of cube NTMs (D4) on 3D printed holders embedded in 
Matrigel solution after compaction in the molds. To the right, confocal image of neurites 
extending between two installed cube NTMs (Scale bar: 1mm; 50 µm). (d) Compaction of toroid 
shaped NTM during the first 4 days, and percent change of thickness [(Outer Radius at D4 – 
Inner Radius)/(Outer Radius at D0 – Inner Radius)*100] (Scale bar: 1mm). (e) Confocal of 
compacted toroid NTM (Scale bar: 1mm). (f) Installation of toroid NTMs (D4) on functionalized 
glass cylinders after compaction in the mold. To the right, a LightSheet image of neurites 
extending throughout the glass rod (β-TubIII: green and F-actin: yellow; Scale bar: 1 mm; 500 
µm). 
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Figure 3-9. Section of a Toroid Tissue after being cut, keeping its original curvature. (Scale bar: 
1 mm) 
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Figure 3-10. Engrafting neuronal populations within fibrin hydrogen did not disrupt 
phenotypical maturation. (a) Confocal images of 5 µm thick cryosections for key neural 
populations at D4 and D7 (Scale bar: 25 µm). (b) Fold-expression of RNA expression across 
normalized population targets with respect to house-keeping gene, GAPDH for D0, D4 and D7 
(n=5) [Targets for excitatory neurons (blue): AD-Adora2a, GR-Grin1, TH-Tyrosine 
Hydroxylase/ Targets for inhibitory neurons (yellow): PV-Parvalbumin, GA-Gad1/ Targets for 
Motor neurons (green): MN-Mnx1, CH-ChAT/ Targets for supporting cells (purple): GF-GFAP, 
CN-CNPase]. (c) Comparison between mouse EBs (gray) and NTMs (red) of RNA expression 
for the population targets with Ctadj<35 @ D7 and with respect to GAPDH, normalized to D0 
(nMEB=4, nmT=5; *p<0.05 T-test). (d) Histology of NTM slices at D7 (Scale bar: 200 µm). (e) 
Histograms of cell position from the nearest edge of the slice, shown in cumulative percentage 
(top) and percent of total per 20 µm bins (bottom).  
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Figure 3-11. Linear fitting of standard curves of PCR targets. 
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Figure 3-12. Development of neural populations in embryoid bodies. (a) Confocal images of 5 
µm thick cryosections for key neural popula-tions at D4 and D7 in mEBs. (Scale bar: 50 µm) 
Fold-expression of RNA expres-sion was shown across normalized population targets with 
respect to house-keeping gene, GAPDH for (b) D4 and (c) D7. (n=4) 
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Figure 3-13. Cycle threshold values for population targets for D0, D4 and D7, for mEB (green) 
and tissue (blue) samples. (whiskers represent SD, nmEB=4; nmT=5) 
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Figure 3-14. Porosity on 3D nerve tissue. (a) Scanning electron micrograph of 3D nerve tissue 
with zoom in. (Scale bar: 10 µm) (b) Pore area. Box assigns 25-75 percentile, solid line 
represents the median, dashed line represents the mean. 
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Figure 3-15. ECM secretion within 3D nerve tissue. (a) Confocal images for fibrinogen (to stain 
the fibrin hydrogel), and four ECMs related to CNS development at D4 and D7. (Scale bar: 50 
µm). (b) Comparison between mouse EBs (green) and tissues (blue) of RNA expression for the 
ECM targets from (a) with Ctadj<35 @ D7 and with respect to GAPDH, normalized to D0. 
(nMEB=4, nmT=5) 
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Figure 3-16. Optogenetic 
neural tissue mimics are 
spontaneously active and 
also develop connectivity 
across the construct. (a) 
Phase contrast image of a 
rod NTM on an MEA 
with electrodes colored 
for the corresponding 
averaged measured firing 
rate (FR) (Spike (SP)/s) 
for D16. Expansions show 
overlay of all action 
potentials recorded in 2 
seconds for an electrode 
far from the NTM (top) 
and an electrode directly 
under the NTM (bottom). 
(b) Firing Spike and Burst
Rate for 20 highest
recording electrodes for
two NTM samples (red
and blue) across 16 days
(Installed on MEA at D4,
started recording 2 days




all electrode channels for
rod NTM for D16. Left
legend corresponds to
electrode position. (d)
Phase contrast image of a




value normalized to unity
for D16. (e)
Representative image of focused stimulating incident beam size on the NTM with respect to the section of 
the structure that is over the recording electrodes for the cube (top), rod (middle) and toroid (bottom). (f) 
Matrix showing firing rate per electrode, where each element corresponds to each electrode on the MEA 
for the cube (top), rod (middle) and toroid (bottom). Matrix on the left corresponds to the average firing 
rate during 20 seconds prior to stimulation, matrix in the center corresponds to the firing rate during 20 
seconds of pulsed stimulation illuminated the section of the NTM farthest from the sensing electrodes (for 
rod and ring), and matrix in the right corresponds to the average firing rate during 20 seconds after 
stimulation. (g) Firing rate prior (Pre; red), during (Stim; blue) and after (Post; red) stimulation for four 
stimulation repetitions done on two separate NTMs for the three shapes: cube (top), rod (middle) and 
toroid (bottom) (nCube=4, nRod & Toroid=8; *p<0.05 ANOVA with Tukey Post Hoc). 
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Figure 3-17. Burst Parameters. Bursting was measured and quantified for two tissue samples 
(red and blue) across 16 days through 4 parameters: (a) percent of spikes fired during bursts 
versus all fired spikes, (b) average number of spikes per burst and (c) average duration of bursts. 
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Figure 3-18. Cross-correlation matrix across all active electrodes and mapping to the respective 
MEA position for the quantification of synchronous activity. 
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Figure 3-19. Bird’s eye image of the placement of the tissues on the MEA of Figure 6 i-k for the 




Figure 3-20. hESC-derived neural tissue mimics compact similar to mESC-derived and respond 
to drugs. (a) Compacted cube NTM formed from hESC at D4. (b) Percent of compaction of the 
sides [(Average Length at D4)/(Average Length at D0)*100] (n=4; Scale bar: 1mm) (c) 
Histology of hESC-derived NTM slices at D10 alongside percent of cell count in 100 µm bins to 
total cell count from histology slices, normalized to 1 [%𝑖 =






(Scale bar: 200 µm). (d) hESC-derived cube NTM on MEA, extending processes with 
representative action potentials recorded from spontaneously firing (Scale bar: 200 µm). (e) 
Average spike and burst rate during recording of spontaneous activity at D10  (f) Fold-change of 
average firing rates across active electrodes (𝑙𝑜𝑔[𝐹𝑅𝑝𝑜𝑠𝑡 𝐹𝑅𝑝𝑟𝑒⁄ ]) for six samples between post
and pre states corresponding to either addition of drug or washes (AP5:SP → Firing rate after 
adding D-AP5 with respect to the spontaneous firing rate; SPpw:AP5 →Firing rate after washout 
with respect to the firing rate during the presence of D-AP5; GABA:SPpw →Firing rate after 
adding GABA, with respect to the firing rate post washout; BICU:GABA → Firing rate after 
washing out GABA and adding bicuculline, with respect to firing rate during the presence of 
GABA) (n=6; *p<0.05, T-test). (g) Representative electrode recording for (from top to bottom): 
spontaneous, D-AP5, spontaneous post-washout, GABA and bicuculline. Effect of drugs on 
bursting was evaluated for the recorded bursts through (h) burst duration and (i) spike frequency 
within each burst. 
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Figure 3-21. Stains for neuronal populations after differentiation from hESCs 
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Figure 3-22. Representative confocal images of hESC-derived cube tissues seeded on MEA in 
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CHAPTER 4: SIMULATION AND FABRICATION OF STRONGER, 
LARGER AND FASTER WALKING BIOHYBRID MACHINES1 
4.1 INTRODUCTION 
While engineering biohybrid robots that utilize hydrogels as biomaterials and biocompatible 
scaffolds has become a growing field in the last decade, the design approaches have been mostly 
by trial and error.(1–7) This can be particularly disadvantageous considering the large amount of 
time and resources required to perform design troubleshooting. This points to a necessity of 
improving upon the method of designing function-specific biological machines.  These soft 
robots primarily consist of actuating cells, such as cardiac or skeletal muscle cells, within or 
around a hydrogel which permits the differentiation and maturation of these cells while 
providing structural and physical cues for the formation of functional (i.e. contracting) tissue. (3, 
8–11) The scaffolds provide the ‘form’ and are used to convert the ‘function’ from the tissue into 
a controlled output, for example some manner of locomotion such as swimming or walking.(1, 
4–6, 12) These scaffolds can be highly customizable through development of 3D printing 
techniques such as stereolithography, which permit these biological machines to have multiple 
shapes, and applicable to numerous muscle tissue geometries and functional outputs.(8, 10, 11, 
13, 14) Despite this design flexibility, in order to achieve effective forward engineering of 
biological machines with targeted performance, a critical necessity is the ability to model the 
1 This section is a reproduction of the following first authored journal article:  
Pagan‐Diaz, G. J., Zhang, X., Grant, L., Kim, Y., Aydin, O., Cvetkovic, C., Ko, E., Solomon, E., Hollis, J., Kong, H. 
J., Saif, T., Gazzola, M., Bashir, R. Simulation and Fabrication of Stronger, Larger, and Faster Walking Biohybrid 
Machines. Adv. Funct. Mater. 2018, 28, 1801145. https://doi.org/10.1002/adfm.201801145 
Author Contributions: G.J.P.-D. designed research, performed research, analyzed data; X.Z. and M.G. contributed 
the computational models and analysis of data and also provided the Appendix 1, L.G., Y.K., O.A., C.C., C.K., E.S., 
J.H., J.K. and T.S. performed experiments and contributed with analysis; R.B. led project and designed research,
G.J.P.-D., X.Z., M.G. and R.B. wrote and edited the paper.
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interaction between the contractile tissue and its interaction with the actuating scaffold to predict 
its functional output. 
One key factor in order to achieve ground up engineering of new biohybrid systems is to 
analytically characterize new design parameters in order to expand the breadth of possible 
applications. The goal is to design these biological machines with a high degree of control, 
tissue-to-scaffold dynamics, and longevity, among other parameters.  Such advances include the 
use of light to temporally control muscle contractions, micro-patterning to achieve spatial 
coordination of contraction, and incorporation of biomolecules to control the degradation of the 
structural matrix.(15–17) 
Force generation to drive actuation is one of the most critical parameters in engineering of 
skeletal muscle tissue constructs. Being able to scale up the force would enable the formation of 
larger or more complex systems, as well as adding new levels of functionality. Currently, the 
largest force achieved in biohybrid tissues has been reported to be 1.18 mN, with a structure of 
four stacks of cardiac 1.16 ± 0.08 cm2 2D sheets of thickness of 45 ± 8 μm.(18) However, this 
was achieved on a fixed scaffold. While untethered biological machines have been designed to 
walk, their current force per stroke during external stimulation was 200 μN for a design with a 
largest dimension of 6 mm.(19) There are many biological factors that affect force generation in 
myogenic tissue, such as the cell source or biomolecular pathways that regulate the metabolism, 
or differentiation of the myofiber type.(20) However, these are hard to control and often require 
a complex regulation of gene expression.(21, 22) Another approach would be to have the 
biohybrid material respond to environmental cues that can be directly engineered. A number of 
studies have employed exercising the muscle during maturation through a series of mechanical 
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stretches or electrical stimulations and have shown >2-fold increase in force generation post-
exercising regimens.(23–25)  
In the present work, we expand upon our prior walker bio-robot (bio-bot) design by 
developing a new tissue fabrication protocol that increases the force per single actuator by 
generating longer myotubes and proposing a mathematical model to develop a predictive 
computer simulation based on empirically calculated force parameters characteristic to the 
biohybrid tissue (Figure 4-1). Our model is based on assemblies of Casserat rods, i.e. slender, 
soft and shearable elements.(26) By varying mechanical properties and by enabling contractile 
stresses, we can model both scaffold and living tissue as well as their dynamic interactions. Once 
calibrated with experimental data, we employed these simulations to effectively modify the 
tissue morphology and contractile characteristics of these biological machines to pointedly scale 
the force to a higher range than has been previously reported, in order to power the actuation 
centimeter-scale skeleton structure (2 times larger than prior design). Specifically, a larger 
number of single actuators was achieved by increasing the tissue volume while controlling tissue 
thickness to avoid limitations of nutrient-diffusion and a larger, stiffer scaffold was designed to 
maintain functionality of the bio-bot driven by a higher-force generating muscle tissue, as 
previous designs would collapse under the larger force. Finally, critical factors are further 
quantified to revise computational models. By implementing this new modeling approach, we 
could predict and validate designs, thus enhancing the efficiency of forward engineering these 
biohybrid systems and serve as new design tools to successfully develop the next generation of 
biohybrid robots from the ground up. 
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4.2 MATERIALS AND METHODS 
4.2.1 SIMULATION AND MODELING 
Muscles are considered as bundles of quasi one-dimensional filaments, which can have large 
deformations in multiple directions. To capture this physics, a numerical method(26) based on 
Cosserat rod theory(27) is implemented for the muscle simulation, which solves the dynamic and 
deformative problems of soft rods with large deflections. For the sake of modeling the entire 
system with one set of equations, same theory is leveraged for modeling the skeleton. Thus, in 
simulation, an assembly of one-dimensional rods with rectangular cross-sections constructs the 
skeleton, whose mechanical properties are essentially preserved. Detailed explanations are 
presented in Appendix 1. 
Interactions within multiple filaments, and between filaments and environments are also 
included in the simulation. Repulsive forces are generated when the muscle is in contact with the 
pillars, eliminating all the interpenetrations. Formulations and implementations of the interaction 
schemes are also included in Appendix 1. Coulomb friction model is applied at the surface 
between the pillars and the ground, while hydrodynamic forces are applied to the entire 
body(26). 
4.2.2 2D MYOBLAST CULTURE AND DIFFERENTIATION 
C2C12 murine myoblasts were seeded at 0.3e6 cells/well in a cell culture six-well plate and 
cultured in muscle growth media (mGM) consisting of Dulbecco’s Modified Eagle Medium with 
L-glutamine and sodium pyruvate (DMEM, Corning Cellgro) supplemented with 10% fetal
bovine serum (Lonza), 1% L-glutamine and 1% penincillin-streptomycin (Cellgro Mediatech, 
Inc.). When cultures reached 80-90% confluency at approximately 2-3 days, media was switched 
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to muscle differentiation media (mDM). Differentiation media consisted of DMEM 
supplemented with 10% horse serum (Lonza), 1% L-glutamine and 1% penicillin-streptomycin. 
2D differentiation was continued for 5 days, changing media daily. All cultures were kept in 
incubators at 37oC and 5% CO2. 
4.2.3 FORMATION OF 3D SKELETAL MUSCLE TISSUE 
The construction of myoblast formed (MB) skeletal muscle tissue followed previously 
published protocol.(6) In summary, each muscle ring was formed from a solution of 0.5e6 
myoblasts mixed with 30% Matrigel (Corning), 4mg ml-1 fibrinogen (Sigma-Aldrich) and 1 U 
per mg-1Fibrinogen of Thrombin (Sigma-Aldrich) and mGM was added for a total of 100uL of 
solution. Each cell-fibrin solution was dispensed to a PEGDA mold and permitted to compact for 
3 days in mGM before being switched to mDM supplemented with 1X aminoproic acid (ACA, 
Sigma Aldrich).  
Myotube formed (MT) skeletal muscle tissue rings were formed analogously to MB rings. 
Differentiated 2D myotubes were trypsinized with TrypLE and delicately triturated mechanically 
to achieve a single cell suspension without breaking the myotubes. Half the cell contents of a 
single well were used for a single MT ring by using the same ECM-Fibrin hydrogel composition 
used for MB rings.  
4.2.4 DESIGN AND 3D PRINTING OF MOLD AND SKELETON STRUCTURES 
Biobot ring molds and skeletons were 3D printed using a customized stereolithography 
apparatus (SLA 250/50, 3D Systems). Ring molds were fabricated using 20% w/v PEGDMA 
M.W. 1000 g mol-1 and skeletons were fabricated from 20% w/v PEGDA M.W. 700 g/mol. Both
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solutions also contained 0.5% w/v of the photoinitiator Irgacure 2959 (Ciba). Fabricated parts 
were sterilized in 70% EtOH for 1 hour and then stored in PBS prior to use. 
4.2.5 ELECTRIC STIMULATION 
A waveform generator was used to depolarize muscle tissue by connecting to a AD797 
inverting amplifier. Square pulses were converted into biphasic pulses by connecting a capacitor 
C in series turning the system into an RC circuit. This was done to avoid electrolysis of the cells. 
Two parallel platinum wires were held in place by a square acrylic well that could be fitted into 
the 6-well plates where the junction bots were places for measurement. Each wire was connected 
to the electrode contacts to run an electrical current perpendicular to the muscle from the cathode 
to the ground.  
4.2.6 MEASUREMENT OF FORCE AND LOCOMOTION 
Muscle actuation was recorded through a stereomicroscope (MZ FL III, Leica Microsystems) 
by using a digital microscope camera (Flex, SPOT Imaging Solutions) to image junction bots 
with pillars facing the camera at a frame rate of 6 f s-1. The bending of the junction bot’s beam 
was correlated to the pillar deflection in response to the contraction of the muscle. This 
displacement was measured in ImageJ (National Institutes of Health). Passive tension force was 
then calculated using the Euler-Bernoulli beam-bending theory: 
𝐿2𝑙𝑃 = 𝑘 ∗ 𝛿𝑚𝑎𝑥; 𝑓𝑜𝑟 𝑘 = 
8𝐸𝐼
         (Equation 1)
,where 𝛿𝑚𝑎𝑥 is the measured deflection displacement. The other constant values were calculated 
for the beam, where I is the moment of inertia, L is the longitudinal dimension and l is the 
moment arm from the point of applied force if the tissue to the beam. E represents the Young’s 
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Modulus, which was previously measured to be 319 kPa, for the chosen fabrication parameters. 
Stimulated tension force was calculated with the same model, using the transient deflections 
displacements produced by the contractile force of the skeletal muscle tissue under electrical 
stimulation at varying frequencies. 
4.2.7 IMMUNOFLUORESCENCE IMAGING 
Prior to staining, muscle tissue was rinsed with PBS and fixed in 4% (v v-1) of 
paraformaldehyde for 20 minutes on the skeleton structure to conserve the tissue structure during 
steady state. Samples were then washed with PBS three times and removed from the structure by 
cutting the PEGDA pillars. Triton-X was diluted to 0.25% (v v-1) and used to permeabilize the 
tissue membrane for 20 minutes. After washing with PBS, samples were blocked and stored in 
1% (w v-1) bovine serum albumin (Sigma Aldrich) at 4 oC until ready to stain (no more than 2 
weeks). 
Cell membrane was immunolabeled with a 1:200 dilution of 488-conjugated antibody 
reactive to F-actin, by incubating overnight at 4 o C. The primary antibodies, mouse anti-myosin 
heavy chain (MF-20) and rabbit anti-α-actinin, were used to stain for myosin and the sarcomere 
respectively at a 1:500 dilution. Tissues were incubated with the primary antibodies for 12 hrs at 
4 o C. Samples were then washed three times before staining with secondary antibodies. 
AlexaFluor-647 anti-mouse (ThermoFisher) and AlexaFluor-633 anti-rabbit (ThermoFisher) was 
used to stain MF-20 and α-actinin primary antibodies respectively and incubated for 2 hr at room 
temperature.  
To be able to image 3D tissue without distorting the internal cellular structure, stained 
samples were fitted into a custom-made PDMS mold, embedded in 1% agarose and covered with 
109 
a coverslip to ensure the agarose surface would be even. These molds were plasma bonded to a 
microscope slide. For imaging, the slides were flipped with the agarose facing the objective for 
high resolution confocal imaging. 
4.2.8 ALIGNMENT QUANTIFICATION 
The orientation of myotubes was quantified using the Directionality plugin for ImageJ which 
uses Fourier component analysis, which computes a histogram which counts the amount of 
myotubes in a given direction, numbered as degrees.(28) Because myotubes show a preferred 
direction, the calculated histogram shows a singular peak at that orientation. A Gaussian fit is 
calculated from the highest peak.  
Fluorescent imaging was used to visualize the myotube membranes on the junction stained 
with conjugated F-actin. Images were uploaded to ImageJ and cropped to include only the region 
of the muscle junction. Fourier power spectra was later computed using the Directionality plugin. 
All samples showed a goodness of fit above 0.9.  
4.2.9 MYOGENIC MATURITY ASSAYS 
Biobot muscle rings were rinsed in PBS, snap frozen in liquid nitrogen for 5 min, and stored 
at -80°C. To analyze muscle creatine kinase activity, samples were thawed at room temperature. 
The muscle tissue was broken up using a pair of micro-scissors, and 300 µL of RIPA buffer 
(Thermo Scientific) was added to the sample. Samples were vortexed, then rocked at 4°C for 30 
min to break apart the tissue. Samples were then sonicated at a power of 1 Watt for 
approximately 10 seconds, or until no visible pieces of tissue remained. The samples were then 
centrifuged for 15 min at 14,000 G and 50 µL of supernatant was mixed with 1 mL of warm 
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creatine kinase working reagent, prepared according to the supplier’s instructions (liquid creatine 
kinase reagent set, Pointe Scientific Inc). 100 µL of the mixture was then transferred to a 96 well 
plate, which was incubated at room temperature for 2 min. The plate was read at 340 nm, with 
seven readings taken at 1 min intervals at 37°C. MCK activity in U/L was calculated from the 
change in in absorbance with time.   
4.2.10 VIABILITY ASSAY 
The MTS assay working reagent was prepared by combining MTS solution (CellTiter 96 
AQueous One Solution Cell Proliferation Assay, Promega) with warm DMEM (without phenol 
red) in a 1:5 ratio. Muscle rings were rinsed in PBS, placed in individual wells of a 24 well plate, 
and immersed in 360 µL of MTS working reagent. The reaction proceeded in the dark for 4 
hours at 37°C. Absorbance at 490 nm was used to measure metabolic activity, and thus cell 
viability. 
4.3 RESULTS 
4.3.1 FORMATION OF BIOLOGICAL MACHINES THROUGH CRITICAL DESIGN 
PARAMETERS.  
The design of the walker bio-bot consists of two pillars, or legs, connected by a beam. 
Differentiated muscle tissue is held between the two legs and as it contracts, it exerts force on 
these legs causing the flexible beam to bend. As the beam deforms, the tip of the pillars come 
close to each other and as the muscle relaxes so does the beam, returning the pillars to its original 
position. This muscle-pillar-beam design mimics the muscle-tendon-bone relationship found in 
vivo. The skeleton structure of the bio-bot is fabricated by using a modified stereolithography 
apparatus (SLA) to 3D print a poly (ethylene glycol) diacrylate (PEGDA) hydrogel from a 
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computer aided design tool. (Figure 4-2.a) The biohybrid tissue is then engineered by mixing a 
suspension of C2C12 mouse skeletal myoblasts with extra-cellular matrix (ECM) proteins 
fibrinogen and thrombin, and injecting the mixture into a 3D printed PEGDA mold, to allow for 
gelation (Figure 4-2.b). This results in cells engrafted in a web-like fibrin hydrogel (Figure 4-
2.c).(29) The cell-laden gel subsequently compacts, and compaction is restricted by the stiff
PEGDA mold, inducing tension across the fibrin gel, which serves as a mechanical cue to direct 
the aligned differentiation of myotubes. Differentiated muscle can then be electrically stimulated 
to contract cyclically, which elicits locomotion by a two-anchor gait.  
Force production and functional output can be further engineered by visualizing the muscle 
tissue as a series of actuators (i.e. myotubes) bound together by an inert hydrogel, and addressing 
the geometrical parameters (Figure 4-2.d). The internal muscle contractile stresses may be 
modeled as: 
𝑭𝒎𝒖𝒔𝒄𝒍𝒆 = 𝒏 ∗ 𝑭𝑴𝑻(𝑩) ∗ 𝒔𝒊𝒏(𝜽𝒂𝒗𝒈) = 𝑨𝒕𝒐𝒍 ∗ 𝜸 ∗ 𝝈𝑴𝑻 ∗ 𝐬𝐢𝐧 (𝜽𝒂𝒗𝒈) (Equation 2) 
where FMT and 𝝈𝑴𝑻is the contractile force and stress of individual myotubes, 𝜽𝒂𝒗𝒈 is the mean 
angle of individual myotubes with respect to the lateral axis of skeleton actuation, 𝑨𝒕𝒐𝒍 is the 
cross sectional area and 𝜸 is the ratio of live actuatingto necrotic tissue. From this relation, the 
net force of the contracting tissue is a function of the force production of individual myotubes, 
which has been shown to be proportional to myotube length, B. (30) Thus, by increasing the 
number and length of myotubes, force can be linearly scaled up. This can be achieved by 
enlarging the tissue volume (L*W*t). However, there is a nutrient diffusion limitation of about 
200μm from the tissue surface, which caps the practical t that can be designed before cell death 
occurs and a necrotic core forms impeding further force production. (31) Finally, Equation 1 
implies that the net force for a given biohybrid muscle is maximized when all myotubes are 
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aligned parallel to the direction of actuation. Given this, the output force at the pillars can be also 
expressed as F = k (x), where k is the stiffness constant of the scaffold against which the tissue 
is contracting, and x is the displacement of the scaffold pillars. Hence, if the tissue size and 
resulting myotube force is increased, the scaffold also must be redesigned to avoid collapse of 
the scaffold.  
4.3.2 INCREASING FORCE PRODUCTION OF INDIVIDUAL MYOFIBER. 
The first parameter that was targeted was the myotube length, as that would increase the 
force baseline for any subsequent design of any given biohybrid actuator. To increase the length 
of myotubes, we added a differentiation step in 2D prior to suspension of the cells in the 3D 
fibrin hydrogel as opposed to inducing differentiation of myoblasts (MB) in 3D fibrin hydrogel 
(Figure 4-3a). Substrate stiffness can profoundly affect myogenesis and longer myotubes can be 
obtained surfaces of higher stiffness.(32, 33) Stiffness of fibrin gels formed using a fibrinogen 
concentration of 4 mg mL-1 mixed with 1 unit mg-1fibrinogen is typically <1 kPa, which is much 
softer than polystyrene plastic (~106 kPa).(34) Therefore, myoblasts were differentiated in 2D 
polystyrene for five days until elongated myotubes (MT) were observed (Figure 4-4a) and 
maturation markers were shown to plateau (Figure 4-5). Afterward, standard 3D seeding 
protocols were followed (See Materials and Methods section).  
After engrafting myotubes in the 3D fibrin hydrogel, the bio-hybrid tissue showed no 
significant change in differentiation markers (Figure 4-6) indicating that bio-hybrid tissue 
development mainly consisted of myotube alignment and remodeling of extracellular matrix. 
After 2-weeks of maturation, MT tissue showed analogous structural characteristics comparted to 
MB tissue (Figure 4-4b; Figure 4-7). However, within the muscle, individual myotubes showed a 
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1.5-fold increase in length for MT samples (Figure 4-4.c; Figure 4-3b) indicating a higher degree 
of myogenic differentiation, which is corroborated by a significant increase in fusion index (FI) 
and concentration of the muscle creatine kinase (MCK) (Figure 4-3c,d).(35) It is important to 
note that there was no significant change in viability (MTS) between MT and MB tissue, 
indicating that changes in differentiation markers were not caused by increased cell numbers 
(Figure 4-3e). 
The resulting forces were then compared between the MB and MT tissue, by installing them 
into the untethered 3D PEGDA skeletons (Figure 4-2b, Figure 4-4b). The force in these two 
constructs was correlated to the beam deflection using the Bernoulli-Euler model. After muscle 
maturation, the muscle develops a passive tension, which deflects the beam by a certain length. 
During electrical stimulation at constant frequency, both MB and MT bots showed cyclic 
contractions corresponding with the stimulation frequencies (Figure 3.d; Figure S1.f). Moreover, 
MT bots showed a substantial force increase when electrically stimulated. The force elicited per 
stroke from the MB bots was consistent in magnitude to previously reported constructs. (25) 
Contrastingly, the MT muscle tissue showed a 3-fold increase in force per stroke across different 
stimulation frequencies (Figure 4-4e). This indicated that the a priori differentiation of cells 
before they are integrated into the matrix results in increased myotube length leading to higher 
forces per stroke as expected. 
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4.3.3 ROD-BASED SIMULATIONS FOR DESIGN OF NEXT GENERATION BIOLOGICAL 
MACHINES.  
In order to design a larger and stronger bot in a targeted fashion, we needed to optimize 
around both the biological and mechanical constraints. Aiming to effectively actuate on a 
skeleton structure 2X larger than previously reported walkers, a muscle structure capable of 
applying millinewton level forces was required.(19) This required a larger muscle structure. One 
of the limitations of designing biological tissue with a larger geometric latitude is that the 
nutrient and waste diffusion will be hampered past the limit of about 200 μm.(36) This will cause 
a necrotic core to form for cells farther than the diffusion distance, resulting in scar tissue and 
impeding the actuation and increase of force (Figure 4-2d). To overcome this, a mold was 
fabricated with a new design which was an integration of our prior muscle ‘strip’ and muscle 
‘ring’ bio-bot design model (Figure 4-8a) (6). This new design can be implemented for larger 
planar geometries, while avoiding the necrotic core by controlling the thickness of the actuating 
tissue and maintaining the modularity of the process to increase the design window.  Following 
the MT tissue differentiation protocol explained in Figure 4-4, myotube/ECM solution was 
dispensed on a mold with a shallow trench enabling the formation of a thin tissue region. This 
400 μm deep trench would ensure that compacted tissue thickness was below the nutrient 
diffusion limit from either side.  
This design was guided by the mechanical model of the muscle tissue, which was 
incorporated in a novel rod-based formalism for the simulation of arbitrary musculoskeletal 
structure .(37) (Appendix 1) The simulation approach aimed to model both the skeleton of the 
bot and the muscle tissues, with the capacity of capturing the dynamic responses during beam 
deformation and muscle contraction. Assembling of the junction bot for simulation purposes 
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consists in setting the force generation model of the skeletal muscle tissue (Figure 4-8b). Aiming 
to design bio-hybrid robots with arbitrary muscle arrangement and the structure of the skeleton, a 
general relationship was expanded from Equation 1 between the stimulated muscular stress 
𝝈𝒎𝒖𝒔𝒄𝒍𝒆 = 𝑭𝒎𝒖𝒔𝒄𝒍𝒆/𝑨𝒕𝒐𝒍 and force output to 3D scaffolds 𝑭𝒐𝒖𝒕, where 𝑨𝒕𝒐𝒍 is the overall cross-
sectional area of the muscle. A force model was thus proposed which involved, the ratio of the 
area of active muscle cells 𝜸 = 𝑨𝒂𝒄𝒕/𝑨𝒕𝒐𝒍, and the average myotube alignment angle 𝜽𝒂𝒗𝒈. The 
relationship was defined as  
1−𝜀𝐹𝑜𝑢𝑡 = 𝐴𝑡𝑜𝑙 (𝛾𝜎𝑚𝑢𝑠𝑐𝑙𝑒 − 
𝐸𝑚𝑢𝑠𝑐𝑙𝑒𝜀)     (Equation 3)
where 𝐸𝑚𝑢𝑠𝑐𝑙𝑒 is the muscular Young’s Modulus and  denotes the strain of the muscle 
tissue. The latter term conveys the axial rigidity and the radial deformative behavior of the 
muscle. Furthermore, the overall stress is comprised of the passive and active elements, 
formulated as 𝜎𝑚𝑢𝑠𝑐𝑙𝑒 =  𝜎𝑝𝑎𝑠 + 𝜎𝑎𝑐𝑡.  
In order to design a larger bot, or more general biohybrid bot with arbitrary configuration, 
𝜎𝑚𝑢𝑠𝑐𝑙𝑒  has to be defined as the functional input. Here, 𝜎𝑚𝑢𝑠𝑐𝑙𝑒  is derived based on the force 
characterization of the MT bot, which has been demonstrated to have the desired force increase 
(𝐹𝑜𝑢𝑡 = 2.6𝑚𝑁). Thus, following Equation 2 and given the geometrical parameters (𝐴𝑡𝑜𝑙 =
1.08𝑚𝑚2, 𝛾 = 0.83, 𝜃𝑎𝑣𝑔 ≈ 90°), we have 𝜎𝑚𝑢𝑠𝑐𝑙𝑒=10.39𝑚𝑁/𝑚𝑚
2. For the muscle
arrangement of the new bot design, the same muscle stress is proposed to apply since the same 
protocol is leveraged. It is also worth noticing that because of the thickness-controlled design, 
𝛾 ≈ 1. Therefore, from the muscle model, a muscle tissue with cross-sectional area around 
1𝑚𝑚2 is expected to elicit forces Fmuscle>10𝑚𝑁.
A complementary skeleton structure was also computationally designed to handle these 
levels of force and be capable of locomotion. The elastic modulus E of the PEGDA beam (See 
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Materials and Methods section, Equation 3) was kept the same (319.4 kPa) as the small skeletons 
for ease of fabricaiton. However, in order to accommodate the expected increase in force, the 
stiffness constant was increased by increasing the moment of inertia by ~ 5X (small skeleton: 
0.04 mm4; large skeleton: 0.2 mm4) by increasing the beam dimensions accordingly to also be 
suitable for the designed tissue (Figure 4-9). By assembling the muscle tissue with the skeleton 
in simulation, the final configuration of the bot is shown in Figure 4-8b, with the passive muscle 
stress overcoming the intrinsic bending stiffness of the skeleton. The simulation result reveals a 
1.4𝑚𝑁 active force being applied on each pillar upon muscle stimulation, rendering a successful 
steady walking of the new bot. The details of the simulation results are presented later with the 
experimental characterizations. 
 These calculations permitted the fabrication of a centimeter-scale asymmetric skeleton, unto 
which the designed muscle structure could be modularly installed (Figure 4-8c). Due to the 
formation of a thickness-controlled muscle region bridging the tissues that wrap around the 
pillars, this tissue structure was labeled “junction bot”, and for ease of discussion will be referred 
to as such (Figure 4-8d, Figure 4-10). 
4.3.4 EMPIRICAL CHARACTERIZATION OF THE JUNCTION BOT. 
Once the junction bot design was successfully manufactured (Figure.4-8), it was confirmed 
that it could effectively elicit a macroscale deflection of the pillars when stimulated. The samples 
were electrically stimulated at multiple frequencies at 5, 10 and 15 days (5D, 10D and 15D) after 
seeding (Figure 4-11a). As expected, 5D samples showed contraction force below 3% of the total 
force (active + passive) calculated from the beam deflection. However, by 10D and more so at 
15D, contraction force increased to 7.5% and 12.5% of the total achieved force. Passive tension 
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did not significantly change during maturation, averaging around 7.99±0.54 mN, 8.38±0.40 mN, 
and 8.45±0.86 mN for 5D, 10D, and 15D, respectively (Figure 4-11b). Passive tension is 
produced by the protein titin spanning across the half-sarcomere.(38) Therefore, the stable 
baseline in the passive force could be another indication that myotubes have reached steady state 
of differentiation prior to seeding. On the other hand, the active force per stroke increased 
significantly over time (Figure 4-11c). Rate of increase of active force from 10D to 15D was 
smaller compared to that from 5D to 10D, which could be interpreted as sign of plateauing of 
tissue maturation. At stimulation frequencies of 2 Hz and 4 Hz, junction bots were able to elicit 
stroke forces in the range of 1.10 ± 0.30 mN and 1.14 ± 0.25 mN, respectively, which are almost 
6X higher than what was previously achieved for these skeletal muscle actuated walking bio 
bots.(19) Furthermore, similar to native tissue, this engineered skeletal muscle exhibited a 
positive force-frequency relationship, notable at 10D and 15D. (20) In addition, one standard 
deviation around the mean force per stroke at 15D coincided with the calculated force of 0.5 mN, 
1mN, and 1.4 mN as compared to the stimulation frequencies of 0.5 Hz, 1 Hz and 2 Hz, 
respectively, and the resulting computed dynamic deflections of ~0.3mm, ~0.5mm, ~1mm, 
respectively (Figure 4-11d). This provided key confirmation that the muscle-scaffold model 
could serve as a predictive model for force output of engineered muscle tissue. 
4.3.4.1 Empirical effects of geometrical parameters on force output. 
Next, the junction geometry was examined as a parameter that could modulate force output. 
While dispensing myotube-ECM solution on the 3D molds, the solution entirely conformed to 
the mold dimensions followed by a compaction process as the fibrin hydrogel crosslinks (Figure 
4-12a). To quantify the relation between junction dimensions and force production, molds with
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trenches of initial seeding widths (Wo) of 3.5 mm (W3.5), 7 mm (W7) and 14mm (W14) were used 
to dispense myotube-ECM solution and then tested at 15D (Figure 4-12b), at which final width 
had been reached (WF). It was notable that the junction width did not compact linearly, relative 
to Wo (Figure 4-12c). The inter-quartile range (IQR) of the WF for W3.5 junctions was between 
2mm and 3mm, which corresponds to a ~1.58-fold compaction ratio. However, for W14 
junctions, the IQR spanned approximately 4 mm and 6 mm, corresponding to a compaction ratio 
of ~3.08-fold change. This relationship showed that the ratio by which these muscle junctions 
compacted was not constant (relative to W0), but linearly correlated to the logarithm of W0, with 
a slope of 0.75 (Figure 4-12c, top). This was in fact unexpected and could have occurred in 
response to nonlinear dynamics between muscle cells and fibrin hydrogels, and that could be 
intriguing to further study in the future. 
Nevertheless, the resulting force was discernably affected by W (Figure 4-13). The passive 
tension significantly increased from 7.93 ± 0.3 mN for W3.5, to 9.53 ± 0.68 mN for W14, which 
constitutes on average a 1.2-fold increase (Figure 4-12d). This effect from W0 was far more 
perceivable in the force per stroke evoked during stimulation. However, this stimulated force 
exhibited a significant decrease for larger W0 (Figure 4-12e). While junctions seeded at W3.5
reached forces during strokes of 0.97 ± 0.27 mN, junctions of W7 were significantly weaker with 
stroke forces of 0.67 ± 0.26 mN. This trend was even more extensive for W14 junctions, reaching 
relatively weak forces of 0.47 ± 0.17 mN. This negative force per stroke dependence to W0 was 
hypothesized to be a result of a lack of myotube alignment for wider junctions. It is well 
documented that cells align parallel to a hydrogel matrix under a uniaxial tension, by responding 
to both mechanical and topographical cues.(39, 40) Given that all the muscle tissues were 
subjected to the same tensile resistance by the skeleton beam, narrower junctions would result in 
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a more homogenous tension distribution and thus a more aligned cluster of myotubes, compared 
to wider junctions.(41) This would then result in more force per stroke during stimulation, as 
expressed in Equation 1. 
4.3.4.2 Empirical effects of myotube alignment on force output.  
To quantify this force-myotube alignment relationship, fluorescence microscopy was used to 
compare alignment of populations of myotubes within the muscle junction of samples to the 
evoked force response measured prior to fixing samples for imaging (Figure 4-14a). Fluorescent 
images stained for the cellular membranes in the muscle junction were analyzed by ImageJ, 
where myotubes were detected as single elements. By counting the elements at each degree 
between 0 to 180, normal histograms were obtained to quantify population mean (μ) and 
standard deviation (σ) (Figure 4-15). This was performed for junction bots at 5D, 10D and 15D 
(Figure 4-16). Distribution of myotube orientation evolved from an almost uniform distribution 
at 5D (σ > 30) to a normal distribution , plateauing by 15D  (σ ~ 15), as cues from stiffer fibrin 
matrix fibers directed alignment (Figure 4-14b). Furthermore, during tissue maturation, the mean 
of the orientation distribution approached 90o, aligned towards the direction of pillar actuation. 
To elucidate if there was a direct correlation between alignment and force production, the mean 
force per stroke was plotted against both the population mean, μ and the standard deviation, σ for 
three junction bots at 5D, 10D and 15D each. There were two possibilities. The first was that 
alignment played little role in general force production, but rather it was an effect of tissue 
maturation. The second was that either a net alignment of myotubes towards the direction of 
pillar actuation, or a homogenous alignment which minimized cancelation of force vectors from 
misaligned myotube components lead to a larger force production.  
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The produced force at different frequencies of stimulation did have, as expected, a positive 
relationship with μ, and a negative relationship with σ. However, there was no discernable trend 
with either. A positive linear relationship was observable when correlating force produced to the 
ratio of μ/σ (Figure 4-17), and within a same day of measurement, force values consistently 
showed a positive linear trend in relation to the ratio. Interestingly, regardless of the frequency of 
stimulation, the slope of the linear fits seemed to be consistent at around 0.15 ± 0.03 mN*(μ/σ)-1 
(Figure 4-18).  
Finally, force was also correlated with the alignment term of Equation 1 above at each day of 
the measurement (Figure 4-14c).  As a physically relevant measurement of the influence of 
myotube alignment on actuation force, a normalized weighted average was defined as, 𝝌𝜽̅̅̅̅ =
∑ 𝝎′𝒊 ∗ 𝐬𝐢𝐧 (𝜽𝒊)
𝟏𝟖𝟎
𝒊=𝟎 . Here, ω’i is the value of the normalized magnitude component from the 
histograms for each respective degree of alignment in Figure 4-14b. These calculated values 
showed a very high linear relation with the measured force for each respective day, yet 
interestingly, also showed a clear dispersion for values across days. These empirical results 
confirm the relation between force and myotube alignment. This also seems to support our 
hypothesis regarding the effect of junction width to myotube alignment, with respect to force 
production as proposed in Figure 4-12 (Figure 4-18). Nevertheless, the dispersion for force with 
respect to 𝝌𝜽̅̅̅̅   across days of measurement would suggest that the model applies for a specific
day of development as there might be other factors during tissue maturation that affect net 
contraction force. This is an opportunity for future work to fully elucidate such parameters for a 
model that accommodates time as a variable in the development of force.  
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4.3.5 PREDICTIVE MODEL FOR DYNAMICS FOR BIOLOGICAL MACHINES. 
Another essential parameter to quantify during engineering of skeletal muscle-based 
biological machines is the dynamic functional output in response to the contraction force. Here, 
the skeletal muscle construct was fitted onto a PEGDA skeleton to achieve locomotion through a 
two-anchor gait. During stimulation, junction bots were placed with the pillars in contact with 
the substrate and tracked by a video camera as the cycling pillar displacement achieved net 
locomotion (Figure 4-19a). Similarly, by setting the pillars of the computational junction bot 
model in “contact” with a simulated surface with a roughness similar to polystyrene, two-anchor 
gait locomotion was also successfully simulated. Our simulation also demonstrates the dynamic 
variation of kinetic friction coefficients required for forward “inch-worm” locomotion (Figure 4-
19b).(7) It is relevant to clarify that the simulated displacement was achieved by setting an input 
through the modeled tissue, and the skeleton would actuate as an output, thus resulting in an 
interaction with the simulated surface. 
Both empirical and model-predicted position-time curves of junction bots depended strongly 
on stimulation frequency (Figure 4-19c), with the walking speed increasing with increasing 
stimulation frequency. While empirical results and model predictions matched well for 0.5 and 
1Hz stimulation frequencies, agreement was poorer for 2 and 4Hz. This was not unexpected as 
simulating this slip-stick model of displacement is highly dependent on the initial state and, more 
importantly, the interplay between the forward and reverse friction coefficients of which the 
effects become more chaotic at higher frequencies. Therefore, we established that the high-
accuracy of our computational model was limited to oscillation frequencies below 2 Hz (Figure 
4-19b, c shaded area).  On the other hand, it is worth pointing out that this larger and higher-
force producing bio-bot design was able to reach speeds > 0.5 mm s-1 at 4 Hz (Figure 4-19d), 
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corresponding to a ~2-fold increase from previous designs.(6) This demonstrates the 
performance of these biological machines with respect to external stimuli as well as muscle 
geometry. 
An analysis of work exercised on the pillars by the muscle tissue for junction bot showed no 
significant change between stimulation frequencies. However, when comparing with the work 
exercised during locomotion, which was defined as its efficiency, 𝜼 =
𝑾𝒐𝒓𝒌 𝒅𝒖𝒓𝒊𝒏𝒈 𝒍𝒐𝒄𝒐𝒎𝒐𝒕𝒊𝒐𝒏
𝑾𝒐𝒓𝒌 𝒐𝒏 𝑷𝒊𝒍𝒍𝒂𝒓
 (Figure 4-19d), there was a decrease from 0.71 ± 0.21 μJ μJ-1 at 0.5 Hz to  0.46 ± 0.02 μJ μJ-1 at
1 Hz, and then plateaued for higher stimulation frequencies. This implies that, even though 
stimulating at 4Hz can result in significantly higher speeds than at 0.5 Hz, the efficiency at 4Hz 
being only 0.52 ± 0.2 μJ μJ-1 implied higher slipping between the pillars and the substrate. This 
efficiency could be optimized by further treating pillar tips with surfactants or other fabrication 
processes to increase the friction coefficient. This would enable the engineering of biological 
machines to reach even higher speeds with decreased variability. 
4.4 DISCUSSION 
Tissue engineering has had a major focus of employing muscle cells as actuators capable of 
driving a large range of directed functionalities(42). Impressive breakthroughs have been 
achieved using self-contractile tissue, to engineer pumps and structures capable of locomotion.
(1, 4, 5, 7, 43) However, the ability to modulate contractions for controlled outputs and functions 
has made engineering of skeletal muscle biohybrid actuators a central focus of the field (15, 19, 
44, 45). Furthermore, skeletal muscle provides the possibility of engineering motor neuronal 
circuitry capable of controlling contractile output to a higher degree. 
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A critical part of advancing this field of study is to lay the foundation of principles that direct 
the engineering of next generation biological machines. To this purpose, the present work has 
developed a platform that links computational modeling to empirical validation for biological 
machines. This provides a proof of concept of the ability to start designing biohybrid actuators 
with more complex geometries and targeted force outputs which would result in the ability to 
engineer a wider range of function-specific performances. Here, we employed this concrete 
approach to intelligently increase the force output of autonomous biohybrid skeletal muscle 
biobots from ~200 µN to ~1.2 mN to actuate on a PEGDA scaffold that was twice as large as 
previous designs. By differentiating myoblasts on high stiffness substrates, versus 3D 
differentiation, their length was increased 1.5-fold and shown that these can still be effectively 
engrafted in a 3D construct without loss of viability. This length increase caused a force increase 
from each individual myotube actuator within the tissue, thus resulting in a net force increase 
from the entire structure. This length improvement could be further extended by differentiating 
myoblasts in groove-patterned substrates or the use of high-Connexin 43-expressing 
myoblasts.(46, 47) 
Utilizing the computational model, we designed a fitting larger muscle structure by targeting 
and optimizing concrete design parameters while addressing the nutrient diffusion-based 
thickness limit by designing a new mold geometry. This increase of geometry of actuating 
muscle served to further increase the force, where the structures were enlarged from 6 mm (for 
its longest dimension) to 1.3 cm. It was further coupled with a walking skeleton structure 
designed to handle the scaled force. This work also aimed to characterize empirical factors in an 
effort to validate the proposed design criteria, primarily quantifying force to be correlated with 
the degree of alignment of the individual myotubes.  
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The resulting design could have the additional benefit of facilitating the introduction of other 
constructs, such as motor neuronal structures, by providing a physical platform on where to place 
such tissue. This is particularly advantageous since achieving adhesion in these types of 
suspended structures poses a real obstacle during modular approaches to multi-phenotypical 
tissue engineering.(48) Theoretically, a bundle of synthetic motor neuronal circuits that have 
been engineered to contain central pattern generators could be modularly placed on the junction 
for adherence, innervation and neuronal control of the structure.  
We also developed a computational model that was able to simulate the dynamics of the 
muscle and its interaction with the skeleton. This model showed a high correlation with 
empirical force data, and, more importantly, effectively predicted the degree of the functional 
output, e.g. locomotion, with high accuracy. This could therefore be a great aid in the design of 
future biological machines that are able to exhibit more complex behaviors and achieve precise 
tasks with a high degree of control. Using this modeling approach, we can now computationally 
explore new skeleton designs that incorporate targeted modifications to critical structures and 
dimensions such as the beam thickness, pillar length, skeleton mass, etc., to acheieve a specific 
metrics of performance and functionality.  
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4.5 FIGURES 
Figure 4-1. Process flow for the development of a computational predictive model for targeted 
forward engineering of biohybrid actuators 
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Figure 4-2. Design parameters of skeletal muscle biological machine. a) 3D sterelithography 
apparatus was used to 3D print PEGDA resin into the molding and skeleton structures (b) in 
order to guide the formation of muscle tissue and translate muscle contraction to locomotion, 
respectively. c) Biohybrid tissue is formed by mixing C2C12 myoblasts with ECM proteins. d) 
Forward engineering of muscle design for next generation biobots can be modeled as a function 
of muscle geometry of active tissue, and actuator length and alignment. (L: length, W: width, t: 
thickness, θ: myotube alignment, B: myotube length and active area).    
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Figure 4-3. Myoblast a) (MB) formed biobot validation and comparison with myotube (MT) 
formed biobots. b) Viable MB bots showing response to multiple electrical stimulation 
frequencies, were compared against the MT bots in c) fusion index, d) muscle creatine kinase 
concentration, e) myotube length and f) tissue viability. 
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Figure 4-4. Increasing the force baseline by extending myotube length. a) Process flow diagram 
of muscle formation through seeding Myotubes (MT). b) Stereoscopic image an MT (b) bots 
exerting passive force on PEGDA skeleton (scale bar: 1mm). MT formed bio-bot consisting in 
striated bio-hybrid muscle in 3D. c) MT formed tissue was compared to myoblasts (MB) formed 
tissue through various parameters: (ML) myotube length (mean ± SD, n=20), (FI) fusion index –
number of nuclei per multinucleated myotube— (mean ± SD, n=20), (MCK) muscle creatine 
kinase concentration (mean ± SD, n=4), and (MTS) cell viability (mean ± SD, n=4). d) Total 
force output of MT bio-bot for different frequencies of stimulation (0.5 Hz, 1 Hz, 2 Hz and 4 
Hz). e) Force per stroke at different stimulation frequencies (mean ± SD, n=6)  (*p<0.05, 
**p<0.005, ***p<0.0005, T-test) 
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Figure 4-5. Muscle creatine kinase increase (left) during 2D differentiation (right) 
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Figure 4-6.  Concentration of muscle creatine kinase for MT formed muscle strips at 0, 7 and 14 
days after seeding in the 3D mold.  
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Figure 4-7.  Myotube striation for MB and MT bio-bots showed no change in the interval 
between sarcomere bands. 
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Figure 4-8.  Formation of Junction Bot guided by rod-based simulations. a) Process flow 
diagram of myotube/gel solution seeding and tissue formation across a trench mold. b) 
Computational integration of muscle to designed skeleton to model the junction bot and study 
force transmission of the computational model. c) Representation of muscle tissue integrated 
onto a 3D printed PEGDA centimeter-scale skeleton (skeletons drawn to scale). d) (left) optical 
image angled side view of the entire junction biobot structure, (right) Phase contrast image of 
mature junction biobot from the bottom side showing the muscle and the printed hydrogel 
scaffold.  
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Figure 4-9. Dimensions of the mold and skeleton to form the junction bot 
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Figure 4-10. Representative photographs of Junction Bot. 
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Figure 4-11.  Force development of Junction Bot. a) Representative force (mN) response of 
muscle successively stimulated with an electrical field at increasing frequencies (0.5, 1, 2, 4 Hz) 
at 5 days (top), 10 days (middle) and 15 days (bottom) after seeding. b) Passive force at 5, 10 and 
15 days of seeding. (mean ± SD, n=6). c) Force response at different frequencies of stimulation 
for each day of stimulation (5, 10 and 15 days) (mean ± SD, n=6). d) Computationally calculated 
deflection of pillars (black) and resulting force (blue) simulated for 0.5 Hz, 1 Hz and 2 Hz as 
predicted by the model, and falling within the 1 standard deviation of the empirical force of our 
bots at 15 D under respective frequencies of stimulation. . (*p<0.05; **p<0.005; ***p<0.0005, 
T-test).
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Figure 4-12.  Force dependence to junction width. a) Representative image of the compaction 
process. b) Muscle after compaction from junction bots seeded on molds with varying trench 
width: 3.5mm (top), 7mm (middle) and 14mm (bottom) (Scale bar 2 mm). c) Compaction of 
biohybrid muscle, quantified by compaction ratio (WF/W0) (Top; mean ± SD, n=6) and final 
width  (WF) (Bottom) relative to the seeding width (W0) (Bottom; Box plots range: 25/75 
percentiles; n=6). d) Passive force (mN) of mature junction bots (mean ± SD, n=6) e) Average 
active force peak from mature bots at varying seeding trench widths. (mean ± SD, n=6). 
(**p<0.005; ***p<0.0005, T-test) 
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Figure 4-13. Force output of individual junction bots as a function of their respective final 
junction width. 
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Figure 4-14.  Force dependence to myotube alignment. a) Mature (15 D) junction bot showing 
myotube distribution and alignment through confocal microscopy. b) Representative histogram 
of magnitude of Fourier components versus degree of alignment for the myotubes at different 
days of maturation. The change of the dispersion of orientation of the myotubes was quantified 
with the standard deviation across the 5, 10 and 15 days. (Inlet; mean ± SD, n=3). c) Mean force 
produced per sample (mean ± SD, n=4) plotted against the  degree score (angle of alignment (μ) 
divided by the standard deviation (σ)). Data points were linearly fitted ( P<0.01, one-way 
ANOVA).  
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Figure 4-15. Representation of myotube alignment quantification. 
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Figure 4-16. Polar histograms of myotube alignment. 
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Figure 4-17. Junction bot correlation of force to standard deviation (σ) (top, left) and population 
mean (μ) (top, right) for individual stimulation frequencies. Junction bot correlation of  force for 
individual stimulation frequencies (bottom, left) and the average force (bottom, right) to degree 
score (μ/θ). 
142 
Figure 4-18. Correlation of junction width of bots to alignment parameters: orientation mean (μ) 
of myotubes, standard deviation (θ) of myotubes orientations, the degree score parameter defined 
as (μ/θ) and the normalized weighted mean of the sines of the myotube alignments (χθ). 
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Figure 4-19. Functional output of junction bot. a) Snapshots of junction bot locomotion (scale 
bar: 2mm). b) Simulated gait for one period of junction bot displacement by a two-anchor 
mechanism of locomotion (top). The kinetic friction force change for each leg with respect to the 
period (bottom). c) Displacement versus time for different stimulation frequencies (0.5, 1, 2 and 
4 Hz). Points are experimental data and solid lines are modeled junction bots at same frequencies 
of stimulation. d) Speed of displacement between experimental (clear bars) and computational 
(solid) results for different frequencies of stimulation. e) Work per stroke calculated from bot 
displacement multiplied by the force measured for that respective junction bot at the 
corresponding stimulation frequency. (mean ± SD, n=3) f) Efficiency (η) plotted against each 






4.6 COSSERAT ROD THEORY
Figure 4-20. Junction bot correlation of force to standard deviation (σ) and population mean (μ)
for individual stimulation frequencies. 
Converting Beams into Rods Considering a beam shown in Figure 4-20a with length l, width b
and thickness h, the mechanically equivalent conversion to two rods requires the matching of the 










where 𝜌 is the original density of the skeleton. 
Cosserat Theory We describe a rod by a centerline ?̅?(𝑠, 𝑡) ∈ ℝ3 and rotation matrix 𝐐(𝑠, 𝑡) ∈
{𝐝1̅, 𝐝2̅, 𝐝̅3}
−1 which leads to a general relation between frames for any vector 𝐯: 𝐯 = 𝐐?̅?, ?̅? =
𝐐𝑻𝐯 , where ?̅? denotes a vector in the lab frame and 𝐯 denotes a vector in the local frame. Here
𝑠 ∈ [0, 𝐿0] is the material coordinate of a rest-length 𝐿0 rod, 𝐿 denotes the deformed filament 




while 𝐝̅ and 𝐝̅ span the normal-binormal plane. Shearing and extension shift 𝐝̅3 away from ?̅?𝑠,
which can be quantified with the shear vector 𝛔 = 𝐐(𝐱̅𝑠 − 𝐝̅ ) = 𝐐𝐱̅𝑠 − 𝐝3 in the local frame 
(Figure 4-20b). The curvature vector 𝜿 encodes 𝐐’s rotation rate along the material coordinate
𝜕𝑠𝐝𝑗 = 𝜿 × 𝐝𝑗, while the angular velocity 𝝎 is defined by 𝜕𝑡𝐝𝑗 = 𝝎 × 𝐝𝑗. We also define the 
velocity of the centerline ?̅? = 𝜕𝑡?̅? and, in the rest configuration, the bending stiffness matrix 𝐁, 
shearing stiffness matrix 𝐒, second area moment of inertia 𝐈, cross-sectional area 𝐴 and mass per 
unit length 𝜌. Thus the dynamics of a soft slender body is then described by: 
𝜌𝐴 ∙ 𝜕𝑡
2?̅? = 𝜕𝑠 (
𝐐𝑻𝐒𝛔
𝑒
) + 𝑒𝐟̅ (Equation 6) 
𝜌𝐈
𝑒
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𝝎
𝑒
) ×  𝝎 +
𝜌𝐈𝝎
𝑒2
𝜕𝑡𝑒 + 𝑒𝐜 (Equation 7) 
where Equation 6 and 7 represent linear and angular momentum balance at every cross section, 𝑒 
= |𝐱̅𝑠| is the local stretching factor, and 𝐟̅  and 𝐜 are the external force and couple line densities, 
respectively. The discretized model is also shown in Figure 4-20c, which is implemented
numerically (37). 
Interactions Between Filaments  The connection between the beam and the pillar is established 
through force and torque exchanges. Consider the scenario where node 𝐱1(𝑗+1) in rod 𝑅1 is stuck 
onto node 𝐱2(𝑗+1) in rod 𝑅2, while 𝑅1 and 𝑅2 are perpendicular with respect to each other, as 
shown in Figure 4-20.c. Thus the constraining forces exerted to both nodes are proportional to
the position difference: 
   𝐅𝒄 = 𝑘(𝐱2(𝑗+1) − 𝐱1(𝑗+1)) (Equation 8) 
 where 𝑘 is the connecting stiffness of the joint. To ensure the verticality, any off-positional 
displacement should be eliminated by applying restoring torques 𝛕𝒄 on adjacent segments, which 
are derived as 
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= [(𝐱2𝑗 − 𝐱2(𝑗+1)) ∙ 𝐧]𝐧 (Equation 9) 
 𝛕𝒄 = (𝐱2𝑗 − 𝐱2(𝑗+1) + ) × (𝛾 ) (Equation 10) 
where  is an infinitesimal displacement, and 𝐱2𝑗 denotes the nearest node from 𝐱2(𝑗+1). 𝐧 is the 
normal vector of the plane defined by the beam and the pillar, and 𝛾 represents the rotating 
stiffness of the joint. 
We also introduce collision checking between the filaments representing the muscles and the 
pillars (Figure 4-20c). The separating force is composed of linear elastic term, proportional to
the interpenetration displacement, and a damping component that brings energy dissipation into 
the system for the better convergence. The force is then stated as 
𝐅𝒔 = 𝐻( )[𝛽 + 𝜂(𝐯1𝑖 − 𝐯2𝑗) ∙ 𝐝𝑚𝑖𝑛
𝑖𝑗
]𝐝𝑚𝑖𝑛
𝑖𝑗 (Equation 11) 
where 𝐝𝑚𝑖𝑛
𝑖𝑗
 is the minimum distance vector between the two rods, rendering the interpenetration 
to be = (𝑟1𝑖 + 𝑟2𝑗 − 𝑑𝑚𝑖𝑛
𝑖𝑗
). 𝑟1𝑖 and 𝑟2𝑗 denote the radii of the segments that are in contact, with 
𝐯1𝑖 and 𝐯2𝑗 indicating their velocities.  𝐻( ) is the Heaviside function governed by the sign of , 
while 𝛽 and 𝜂 are the stiffness and damping factors respectively. 
Table 4-1 Parameters used in simulations
Parameters Values Parameters Values 
Skeleton Young’s 
Modulus (a) 
319.4 𝐾𝑃𝑎 Skeleton Density (a) 1.12 × 10−3 𝑔/𝑚𝑚3 
Muscle Young’s 
Modulus  
25.0 𝐾𝑃𝑎(49)Error!  Bookmark not defined. Muscle Density  1.06 × 10−3 𝑔/𝑚𝑚3 
(50)





0.42 (52) Dynamic Friction 
Coefficient 
0.3 (52) 
𝑘, 𝛽 108~5 × 108 𝜂 1 
𝛾 5 × 104 
(a) Material properties and geometrical parameters used in the experimental design
(b) Muscular incompressible material assumption
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 FUTURE DIRECTIONS 
5.1.1 ASSEMBLY OF NEUROMUSCULAR BIOLOGICAL MACHINES 
5.1.1.1 Determining appropriate culture conditions for long term stable bio-machine viability 
From the data presented in this work, the next logical step is to take advantage of the 
biofabrication advances and install the neural tissue onto the muscle tissue and examine the 
processes to promote adhesion of these two tissue constructs and functional innervation. The 
latter was shown to be successful by simply placing the neural tissue on top of the junction bot 
muscle construct and incubating for 30 minutes (Figure 5-1a). Due to fibrin-fibrin interaction, 
this results in such strong adhesion that allows for the walker to be flipped, while the neural 
tissue remains adhered (Figure 5-1b). Furthermore, given that the neural tissue was optogenetic, 
some effective interaction was shown through the optical stimulation of the neuron which 
resulted in the contractile response from the non-optogenetic muscle (Figure 5-2a). However, 
given the spastic-like muscle response (contrary to the desired coordinated contraction), it was 
clear that the interaction was still not a functional one (i.e. resulting from stable neuromuscular 
junctions).  While allowing to mature, assembled co-cultures were monitored while also 
stimulating the neurons and observing the muscle response. This not only showed that the 
muscles’ response in response to the neural stimulation diminished with time, but that the 
spontaneous twitching of the muscle also subsided (Figure 5-2b).  
Fearing that the health of the muscle was compromised, co-culture experiments were 
replicated, only this time electrical field was applied to the entire structure. This should have 
resulted in a stimulation of both the neural tissue and the muscle tissue. Therefore, even if the 
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neuromuscular interaction was being somehow impeded, a healthy muscle would still show 
coordinated contractions in response to the electrical pulses. However, within 72hrs, electrical 
stimulation stopped having effect on the muscle construct altogether (Figure 5-3). This indicated 
that the arrangement of the assembly was not only ineffective for developing functional 
interaction but was adversely affecting the myogenic health of the construct.   
In the body, the spinal cord extends processes in the form of nerve extensions throughout 
the muscle fibers in the body, innervating each one individually. Furthermore, both tissues have 
their individual set of supporting cells that provide essential nutrients and growth factors specific 
to the functionality of the different cell types. While NMJ-driven functionality has been shown 
in-vitro to a certain extent, a lot is still unknown about the proper conditions needed to co-culture 
heterotypic constructs composed of neurons and muscle. For one, mimicking the body conditions 
seems to not be viable as these would share general media and thus nutrients, and the spatial 
arrangements as seen in mammals cannot be exactly reproduced for obvious technological 
limitations. Therefore, studies are required to determine effective media cocktails for the 
development of stable and functional NMJs. These would also include study of necessary growth 
factors and possible time dependence of these growth factors with respect to the maturation of 
the NMJ, similar to the time dependence of factors during the differentiation of stem cells. 
Furthermore, determining a compatible spatial arrangement that would effectively catalyze 
innervation might be required, whether it would require physical separation by an ECM or a 
fibroblast or endothelial barrier or a displacement in the positioning of the activating neural 
tissue with respect to the actuating muscle.  
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5.1.1.2 Implementing design principles to optimize and enhance emergence of functionality 
The main factor towards achieving functional NMJs revolves around the adequate 
assembling of neural and muscle constructs such that the MuSK pathway is effectively activated. 
Once activated, MuSK initiates postsynaptic differentiation, preparing the muscle for 
innervation, through the clustering of Acetylcholine Receptors and secretion of factors that 
signal axons. Motor axons recognize the prepatterned muscle fibers, causing them to differentiate 
into specialized junctions. Therefore, since this pathway includes bidirectional communication 
that drives both muscle and neurons towards NMJ formation, engineering methods to trick the 
activation of this pathway could lead to global functional and stable innervation.  
While MuSK becomes activated to a degree spontaneously in skeletal muscle, a molecule 
that catalyzes this activation is the agrin protein. Thus, an idea to achieve this activation is the 
integration of local agrin signaling. This can be achieved by the conjugation of agrin on beads 
that have a diameter similar to nerve terminals. These conjugated beads can be embedded during 
the engrafting of the myotubes in the liquid hydrogel. During compaction and muscle 
development, the conjugated agrin can drive the prepatterning of acetylcholine receptors. This 
would in turn catalyze the NMJ formation and differentiation when the neurons are allowed to 
extend processes across the prepatterned muscle. Through these means, this engineered 
emergence would also result in an interactive functionality capable of driving actuation (i.e. 
walking) of larger scaled biological machines. 
5.1.1.3 Improving biofabrication method for neuromuscular heterotypic living constructs 
While modularity is in many ways an asset to the engineering of these systems, they have 
a major downside: they require a substantial amount of manual processing. This manual handling 
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introduces a lot of heterogeneity in the system, which can result in variability and error. It 
follows that as more modular steps are added, the error propagation would only increase, 
resulting in systems that would not be reliable. As it stands, the proposed paths of assembly for 
heterotypic systems involve such large numbers of manual modular steps.  
To address this, advances in biofabrication presented in this dissertation and proposed in 
the previous sections could be used to develop molds to integrate both neuronal tissue and 
muscle tissue in a single structure that would permit parallel development. This mold would 
likely consist of a similar reservoir used for the junction bot proposed in this dissertation, where 
the solution of myotubes and hydrogel would be added to permit compaction and tissue 
maturation. However, this initial reservoir would likely connect to a raised secondary reservoir 
with a bottom opening exposing the compacted muscle tissue as the “floor” of the secondary 
reservoir. This would then allow for the hydrogel and neuron solution to compact directly on the 
muscle, thus removing the necessity for installation of the neural tissue. This improved 
engineering approach to assembly heterotypic biological systems would greatly depend on the 
constraints and parameters determined in previous subsections of section 5.2.2 and would be an 
excellent example of the interconnection of biological parameters and forward engineering 
approach that this field is aimed towards.  
5.1.2 EXPANDING FUNCTIONALITY OF 3D ENGINEERED NEURAL TISSUE 
5.1.2.1 Engineering programming through training regimens in 3D neural tissue 
In this dissertation a new approach to neural function modulation was provided by using 
a training regimen which consistent of a specific optogenetic pulse sequence applied for an hour 
every 24hrs. This finding evokes a series of intriguing questions. Were the resulting modulations 
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seen in the frequency profile as a function of the stimulation frequency? Would other frequencies 
for the stimulation protocol cause a different resulting frequency profile in the developed 
network? Would changing the rate of making the networks undergo the training regimens or 
prolonging the regimen itself enhance the effects seen in the networks or would they alter them 
altogether? These questions would require numerous splits and sample numbers but would be 
exceedingly useful in elucidating fundamental parameters towards the programming of 
engineered neural networks. Furthermore, this would result in an essential tool in translating 
these findings to the much more tissue engineering-relevant 3D tissues. 
5.1.2.2 Engineering spatial tissue morphologies by connecting circuit specific neural phenotypes 
in 3 dimensions 
One limitation of the biofabrication protocol of neural tissue mimics presented in this 
dissertation is the lack of control of neural populations in 3 dimensions. In the brain, neurons that 
do similar function cluster together, and interconnect across the regions. In a similar fashion 
driving differentiation of separate stem cells towards the enrichment of specific neurons such as 
excitatory, inhibitory and cholinergic neurons and then assembling them together could 
potentially improve the control in functionality of the tissue and enable the engineering of higher 
order complexity. Furthermore, certain clusters could be transfected to express 
channelrhodopsin, and thus be designated as input nodes for the 3D network. The goal would be 
to utilize controlled secretion of neurotransmitters to evoke and control activity of a neural 
tissue, by engineering tissues with specific phenotypes that can serve as input for other tissues 
grown in parallel and treated as the output nodes.  
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As a proof of concept, neurotransmitters with activation of ligand activated channel 
receptor pathways should be targeted first, due to their faster response time and ligand-specific 
response (i.e. it specifically responds inhibitory or excitatory to a specific ligand). On the other 
hand, metabotropic receptors would be hard to control, since they can have more nuanced 
activation pathways, at many times being both excitatory and inhibitory, while also being slower. 
Something to consider in the design of this biological system is that a high (i.e. 
unbalanced) inhibitory/excitatory population would surely deteriorate or force the network to 
regulate and adapt likely by either expression of receptors that would equilibrate or through 
corresponding potentiation or depotentiation of synapses. Therefore, this should suggest that 
there would be a time dependence to the co-culture of the different type of nerve tissues that 
adequately aligns with the differentiation and maturation of the different populations. 
5.1.2.3 Enhancing functionality of 3D engineered neural tissue through integration of 
conductive biocompatible materials 
A major focus of this field is to achieve hyper-organs by forward engineering the 
functionality of the engineered biological systems beyond the functionality achieved 
endogenously by these systems. One approach is to integrate biocompatible biomaterials. 
Reduced graphene oxide has been shown to improve development of other electroactive cells, 
such as muscle cells, while neurons grown on graphene sheets have shown to improve their 
development. A possible explanation is the improvement of conductivity of the ECM may be 
aiding in the development of these constructs. Due to the connectivity presented in the neural 
tissue mimics proposed in this dissertation, along with the flexibility of arranging micro-
electrodes in convenient arrays, acceleration of action potential propagation in response to the 
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presence of conductive microstructures, such as reduced graphene oxide embedded in the ECM, 
could be studied and designed.  With this in mind, integrating reduced graphene oxide in 3D 
neural constructs in order to achieve higher levels of functionality, connectivity and signal 
transfer would be a relevant study towards determining biohybrid methods to engineer neural 
constructs to be implemented in neural-related engineered multi-cellular living systems. 
5.2 FIGURES 
Figure 5-1 a Representative 
images showing the handling 
of an NTM (neural tissue 
mimic), transporting to the 
muscle of a junction bot and 
permitting them to adhere 
after incubation b 
Representation of the adhered 
NTM on the junction bot 
(Scale bar: 3mm). 
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Figure 5-2 Response of muscle to optogenetic stimulation of adhered NTM a Plot showing the 
contraction displacement (left) and the rate of contraction(right) of a muscle from a junction bot 
as a result of the excitation of a neural tissue mimic through optogenetic stimulation. b Force 
generated by muscle as a result of stimulation of the adhered neural tissue at three different time 
points after adhering the NTM. 
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Figure 5-3 Force generation of a JB-NTM construction as a result of 1Hz global electrical 
stimulation at different time point after installation of the NTM. 
5.3 CLOSING STATEMENTS 
The present dissertation is a part of a focused effort within a quickly growing field of 
engineering complex, multi-cellular systems. This field combines concepts of synthetic biology, 
stem cell biology, tissue engineering and biomaterials, among others to guide the creation and 
understanding of the behavior of tissue constructs. With these tools, multiple studies have 
successfully proposed numerous kinds of biological machines as well as engineering heterotypic 
constructs that show successfully functional interactions. The trend of these advances indicates 
that there is a great potential in the use of multiple cells as smart biomaterials and guide the 
implementation of their cell specific functions to engineer higher-order forms of living machines. 
The implications of this goal propose a new engineering approach to understand the underlying 
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principles of the complexity observed in mammalian organisms. This in turn lays the 
groundwork for a functionality-driven conceptual designs of models designated for biomedical 
research as well as other real-world applications. Works like the one presented in this 
dissertation compose essential efforts that are needed to develop the nascent ideas in this 
emerging field. Nevertheless, in the humbling dancing process of understanding the rules of 
biology, while trying to direct them, even bend them and access the rich potential of 
functionalities found in the complexity of mammalian systems lies a beauty, an artistic 
architecture and a scientific challenge that would and should inspire every single engineer.  
